Recurrent or chronic depression

F5_DEPRESSION_RECURRENT

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions not (F5_SCHIZO or F5_SCHIZOAFF or F5_BIPO	530607
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — F33 Hospital discharge: ICD-10 — F33 Cause of death: ICD-10 — F33 3 out of 7 registries used, show all original rules.	33333
4. Check minimum number of events None	33333
5. Include endpoints None	33333
6. Filter based on genotype QC (FinnGen only)	30250

Control definitions (FinnGen only)

Control exclude: F5_PSYCH_INCLAVO, ANTIDEPRESSANTS

Extra metadata

Level in the ICD hierarchy: C
First used in FinnGen datafreeze: DF10

NAME	F5_DEPRESSION_RECURRENT
CONTROL_EXCLUDE	F5_PSYCH_INCLAVO\|ANTIDEPRESSANTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS	!(F5_SCHIZO\|F5_SCHIZOAFF\|F5_BIPO)
OUTPAT_ICD	F33
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F33
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F33
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Recurrent or chronic depression based on the number of shared cases.

Similar with more cases:

Depression or dysthymia

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	30250	22767	7483
Unadjusted period prevalence (%)	6.93	8.08	3.43
Median age at first event (years)	43.67	42.29	47.89

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
24739: Matched controls
171545

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2476.8

321.4

359

G43.3

ICD-10 Finland

Complicated migraine

7.4

321.2

557

533

T74.1

ICD-10 Finland

Physical abuse

7.1

320.7

574

571

A97

ICPC

No disease

2.0

319.9

4650

17977

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.7

318.3

2013

5440

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.2

316.2

3088

10239

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

+∞

315.8

350

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

315.0

6171

26318

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

313.0

5418

22205

M01AG02

ATC

tolfenamic acid; oral, rectal

2.1

312.5

3563

12577

R96

ICPC

Asthma

2.5

312.2

2342

6894

N06AA22, ,

ATC

84.3

311.3

229

N30.0

ICD-10 Finland

Acute cystitis

2.1

311.1

3793

13738

R06AX27

ATC

desloratadine; oral

1.8

310.3

7433

33647

R51

ICD-10 Finland

Headache

3.1

309.3

1513

3536

X23

ICPC

Fear sexually transm dis female

3.2

308.5

1453

3318

N06DA03

ATC

rivastigmine; oral, transdermal

40.1

307.7

252

SPAT1310

SPAT

Counselling related to known health issue

2.0

307.7

7155

29423

N06CA01

ATC

amitriptyline and psycholeptics; systemic

7.6

307.7

3273

3390

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

681.0

307.7

387

F90.0

ICD-10 Finland

Disturbance of activity and attention

+∞

307.7

2296

IGY02, ,

SPAT

117.3

307.7

659

N05BE01

ATC

buspirone; oral

104.3

307.7

1432

101

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

2.0

307.7

14228

68955

J02AC01

ATC

fluconazole; systemic

2.0

307.7

9916

43341

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

+∞

307.7

423

N05BA12

ATC

alprazolam; oral

15.0

307.7

3956

2152

SPAT1243

SPAT

Psychiatric/psychological examination

52.5

307.7

1441

202

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.8

307.7

2595

6912

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

+∞

307.7

455

D10

ICPC

Vomiting

3.1

307.7

1692

3985

SPAT1240

SPAT

Therapeutic discussion

17.7

307.7

5618

2802

F51

ICD-10 Finland

Nonorganic sleep disorders

+∞

307.7

1484

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

307.7

6703

26834

G47.3

ICD-10 Finland

Sleep apnoea

3.0

307.7

6953

19602

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

+∞

307.7

2239

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

713

P27

ICPC

Fear of mental disorder

31.5

307.7

429

EBA00

NOMESCO Finland

Extraction of tooth

1.8

307.7

8956

40737

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

6.9

307.7

764

783

R06.0

ICD-10 Finland

Dyspnoea

2.4

307.7

6120

20942

N06AX26

ATC

vortioxetine; oral

642.6

307.7

6842

102

R01AD09

ATC

mometasone; nasal

1.8

307.7

11467

55756

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

+∞

307.7

6976

F32.8

ICD-10 Finland

Other depressive episodes

+∞

307.7

894

F60.9

ICD-10 Finland

Personality disorder, unspecified

+∞

307.7

626

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

8.8

307.7

524

419

SAA01

NOMESCO Finland

Simple examination of mouth

2.3

307.7

19081

101117

F41.00

ICD-10 Finland

Moderate panic disorder

+∞

307.7

830

SPAT1234

SPAT

Support of social functional capacity

7.3

307.7

952

940

D09

ICPC

Nausea

3.9

307.7

1362

2545

N06BA04

ATC

methylphenidate; oral

134.1

307.7

2025

114

F43.1

ICD-10 Finland

Post-traumatic stress disorder

+∞

307.7

1587

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

30.5

307.7

483

112

N06AA12

ATC

doxepin; systemic

33.6

307.7

1845

411

P25

ICPC

Phase of life problem adult

10.5

307.7

1853

1308

N89

ICPC

Migraine

5.0

307.7

1285

1852

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.9

307.7

2059

5156

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.2

307.7

6186

22636

N06AX17

ATC

milnacipran; oral

188.1

307.7

557

F41.1

ICD-10 Finland

Generalized anxiety disorder

+∞

307.7

4276

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.0

307.7

10627

46760

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

4.0

307.7

1967

3657

OAA65, ,

SPAT

3.3

307.7

6764

17539

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

307.7

10480

46728

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

116.4

307.7

315

Z01.2

ICD-10 Finland

Dental examination

1.8

307.7

12078

60221

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

+∞

307.7

833

SPAT1246

SPAT

Screening of depression or other psychiatric problem

4.7

307.7

1503

2323

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

+∞

307.7

860

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

+∞

307.7

554

M79.6

ICD-10 Finland

Pain in limb

2.1

307.7

11053

46873

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.9

307.7

6777

28914

M54.5

ICD-10 Finland

Low back pain

2.5

307.7

10142

36772

M03BC51

ATC

orphenadrine, combinations; systemic

2.1

307.7

6658

25786

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

+∞

307.7

2482

M54.4

ICD-10 Finland

Lumbago with sciatica

2.6

307.7

5032

15235

F43.00

ICD-10 Finland

Acute stress reaction mild

+∞

307.7

829

R05

ICPC

Cough

2.0

307.7

6086

24072

IHZ19, ,

SPAT

19.0

307.7

388

144

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

307.7

3033

9737

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.7

307.7

13550

71183

F43.2

ICD-10 Finland

Adjustment disorders

+∞

307.7

556

SPAT1284

SPAT

Extensive health certificate

7.9

307.7

939

848

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

+∞

307.7

448

Z02.7

ICD-10 Finland

Issue of medical certificate

3.0

307.7

1801

4307

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.9

307.7

2834

7234

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

+∞

307.7

576

F32.1

ICD-10 Finland

Moderate depressive episode

+∞

307.7

4646

SPAT1237

SPAT

Psychotherapy

46.4

307.7

304

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

+∞

307.7

521

P81

ICPC

Hyperkinetic disorder

49.9

307.7

348

F10.25

ICD-10 Finland

Alcohol dependence continuous use

+∞

307.7

544

N06AB05

ATC

paroxetine; oral

55.1

307.7

3059

438

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

17.2

307.7

348

142

G44.2

ICD-10 Finland

Tension-type headache

3.3

307.7

4017

9560

M25.5

ICD-10 Finland

Pain in joint

2.0

307.7

8593

35410

IHZ05, ,

SPAT

21.8

307.7

2471

867

ZYC01

NOMESCO Finland

Remote contact by phone

3.8

307.7

1827

3502

Z71.8

ICD-10 Finland

Other specified counselling

2.3

307.7

9214

35801

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

39.8

307.7

616

110

IBA03

NOMESCO Finland

Psychotherapy evaluation

1094.6

307.7

605

SPAT1215

SPAT

Assessment of need for medical rehabilitation

6.0

307.7

1130

1363

R03AC02

ATC

salbutamol; inhalant

2.2

307.7

14175

64529

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

+∞

307.7

621

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

+∞

307.7

724

F43.8

ICD-10 Finland

Other reactions to severe stress

+∞

307.7

993

A02BC03

ATC

lansoprazole; oral

2.1

307.7

6109

23039

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

+∞

307.7

2195

SPAT1263

SPAT

Sampling

1.8

307.7

9414

43841

F34.1

ICD-10 Finland

Dysthymia

+∞

307.7

3689

SPAT1241

SPAT

Extensive assessment of psychosocial situation

35.9

307.7

487

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

63.7

307.7

1567

182

N02BF01

ATC

gabapentin; oral

3.2

307.7

2665

6275

N03AG01

ATC

valproic acid; systemic, rectal

9.6

307.7

1317

994

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

+∞

307.7

6696

P20

ICPC

Memory disturbance

4.2

307.7

1846

3236

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

+∞

307.7

1070

F41.8

ICD-10 Finland

Other specified anxiety disorders

+∞

307.7

1758

SPAT1216

SPAT

Assessment of functional ability

2.6

307.7

2640

7554

IGY99

NOMESCO Finland

Other psychiatric treatment contact

175.6

307.7

1159

F40.1

ICD-10 Finland

Social phobias

+∞

307.7

1654

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2459.8

307.7

1371

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

307.7

3174

10391

L03

ICPC

Low back symptom/complaint

2.5

307.7

8116

27724

R21

ICPC

Throat symptom/complaint

2.2

307.7

6287

22993

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.0

307.7

14260

68945

G43.9

ICD-10 Finland

Migraine, unspecified

4.2

307.7

2091

3651

P76

ICPC

Depressive disorder

270.7

307.7

6467

224

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

+∞

307.7

7337

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

15.4

307.7

1513

722

Z05

ICPC

Work problem

7.8

307.7

1280

1189

R5140

NOMESCO Finland

Monitoring the use of the aid

2.8

307.7

2837

7669

M03BX02

ATC

tizanidine; oral

2.2

307.7

16105

78863

A02BC02

ATC

pantoprazole; systemic

2.4

307.7

16733

79034

P99

ICPC

Psychological disorders other

54.7

307.7

1187

158

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.8

307.7

9758

45442

Z29

ICPC

Social problem NOS

8.2

307.7

584

505

K07.60

ICD-10 Finland

Snapping jaw

3.5

307.7

1486

3064

N06AB04

ATC

citalopram; systemic

52.8

307.7

10442

2339

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

11.5

307.7

522

322

F33.8

ICD-10 Finland

Other recurrent depressive disorders

+∞

307.7

1015

N06AB10

ATC

escitalopram; oral

103.8

307.7

13324

1907

N06AX05

ATC

trazodone; oral

154.8

307.7

1470

P74

ICPC

Anxiety disorder/anxiety state

73.5

307.7

2763

293

K02.1

ICD-10 Finland

Caries of dentine

2.0

307.7

15665

79632

N05CD07

ATC

temazepam; oral

11.1

307.7

2966

2079

IGY02

NOMESCO Finland

Psychiatric monitoring contact

117.6

307.7

1677

106

M03BC01

ATC

orphenadrine (citrate); systemic

2.3

307.7

5957

20467

SFA10

NOMESCO Finland

One-surface restoration

1.9

307.7

14216

71975

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

7361

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.3

307.7

1360

2275

L01

ICPC

Neck symptom/complaint

2.7

307.7

4550

13420

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

733.0

307.7

1302

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

307.7

7010

27325

D01

ICPC

Abdominal pain/cramps general

2.8

307.7

3504

9635

IHZ02, ,

SPAT

65.6

307.7

672

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

4.0

307.7

1460

2644

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

+∞

307.7

646

Z2446

NOMESCO Finland

Social worker

6.8

307.7

2107

2318

S06.0

ICD-10 Finland

Concussion

3.0

307.7

2692

6768

A02BA02

ATC

ranitidine; systemic

2.2

307.7

3593

12176

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

307.7

7373

30558

K30

ICD-10 Finland

Functional dyspepsia

2.4

307.7

2791

8713

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

307.7

5479

20089

N05AN01

ATC

lithium; oral

127.2

307.7

415

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.6

307.7

5125

15753

N06AX16

ATC

venlafaxine; oral

126.9

307.7

11216

1114

J45.9

ICD-10 Finland

Asthma, unspecified

2.4

307.7

4673

15047

N07BB01

ATC

disulfiram; oral

30.9

307.7

1655

397

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.4

307.7

2101

4550

F41.09

ICD-10 Finland

UNS Panic Syndrome

+∞

307.7

1394

E66.8

ICD-10 Finland

Other obesity

4.3

307.7

1922

3273

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

10.4

307.7

546

372

KMAK, ,

NOMESCO Finland

1.7

307.7

12540

64306

WX290

NOMESCO Finland

Other blockage of nerve

2.1

307.7

13304

61959

D11

ICPC

Diarrhoea

3.0

307.7

3590

9070

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

+∞

307.7

395

P01AB01

ATC

metronidazole; oral, rectal

1.9

307.7

9631

42763

P16

ICPC

Acute alcohol abuse

25.5

307.7

534

148

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.8

307.7

1576

3002

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

746.6

307.7

630

N02AX02

ATC

tramadol; systemic, rectal

2.3

307.7

10248

40693

OAB38, ,

SPAT

10.6

307.7

797

535

N05AX12

ATC

aripiprazole; systemic

1360.7

307.7

1351

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.4

307.7

4637

14935

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

307.7

8981

40488

N03AX12

ATC

[U] gabapentin; oral

4.0

307.7

4443

9000

OAB91, ,

SPAT

2.8

307.7

2165

5756

SAA02

NOMESCO Finland

Basic examination of mouth

2.0

307.7

17721

95421

SPAT1238

SPAT

Brief therapy

22.8

307.7

791

248

F41.3

ICD-10 Finland

Other mixed anxiety disorders

+∞

307.7

934

Z73.0

ICD-10 Finland

Burn-out

24.5

307.7

1745

529

N06AA09

ATC

amitriptyline; systemic

10.7

307.7

2959

2146

M01AB05

ATC

diclofenac; systemic, rectal

1.7

307.7

15472

84709

F60.5

ICD-10 Finland

Anankastic personality disorder

+∞

307.7

859

N03AX11

ATC

topiramate; oral

8.7

307.7

770

630

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

279.9

307.7

1044

F61.0

ICD-10 Finland

Mixed personality disorders

+∞

307.7

1084

N05AL01

ATC

sulpiride; systemic

62.4

307.7

442

G47.9

ICD-10 Finland

Sleep disorder, unspecified

5.5

307.7

821

1060

SPAT1307

SPAT

Psychosocial counselling and guidance

11.8

307.7

2875

1889

Z3231

NOMESCO Finland

Registered nurse

2.4

307.7

6587

22231

N06AA04

ATC

clomipramine; systemic

58.8

307.7

612

R53

ICD-10 Finland

Malaise and fatigue

4.2

307.7

7617

16466

A06AD11

ATC

lactulose; oral

3.1

307.7

2549

6153

J01DB01

ATC

cefalexin; oral

1.9

307.7

20030

117959

N02AJ06

ATC

codeine and paracetamol; systemic

2.0

307.7

10942

47955

ICB01, ,

SPAT

49.9

307.7

327

F43.0

ICD-10 Finland

Acute stress reaction

+∞

307.7

1903

WX110

NOMESCO Finland

Infiltration anesthesia

2.2

307.7

18522

98383

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

3.1

307.7

2126

5008

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

+∞

307.7

1074

N06AX18

ATC

reboxetine; oral

136.3

307.7

576

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2947.1

307.7

836

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

+∞

307.7

2636

SPAT1301

SPAT

No procedures

1.9

307.7

6481

26978

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

4.0

307.7

3321

6446

N05CF02

ATC

zolpidem; oral

7.3

307.7

6298

7660

AA1AD

NOMESCO Finland

CT of head and brain

2.4

307.7

5635

18849

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

+∞

307.7

3329

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

+∞

307.7

4029

A04

ICPC

Weakness/tiredness general

4.1

307.7

4670

9175

F50.9

ICD-10 Finland

Eating disorder, unspecified

+∞

307.7

402

N05AX08

ATC

risperidone; systemic

68.2

307.7

1849

203

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

19.0

307.7

455

169

M79.1

ICD-10 Finland

Myalgia

2.5

307.7

3881

11749

N01

ICPC

Headache

3.3

307.7

3624

8591

P03

ICPC

Feeling depressed

54.2

307.7

7978

1493

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.8

307.7

1485

2870

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

+∞

307.7

1571

N05BA02

ATC

chlordiazepoxide; systemic

31.5

307.7

616

139

WZA10, ,

SPAT

44.7

307.7

629

100

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

+∞

307.7

390

N06AX12

ATC

bupropion; oral

222.7

307.7

7351

325

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

+∞

307.7

5586

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.5

307.7

3188

9679

SPAT1389

SPAT

Visit based on need for special support

8.1

307.7

796

703

T36

ICD-10 Finland

Poisoning by systemic antibiotics

69.1

307.7

2200

242

T82

ICPC

Obesity

4.1

307.7

1389

2472

Z3226

NOMESCO Finland

Physiotherapist

2.3

307.7

3967

13127

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.8

307.7

1458

2751

IBA01, ,

SPAT

26.2

307.7

983

271

C07AB07

ATC

bisoprolol; oral

1.8

307.7

8886

41338

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

+∞

307.7

1036

SFA20

NOMESCO Finland

Two-surface restoration

1.8

307.7

15048

78988

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

9.6

307.7

2316

1818

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.7

307.7

807

1001

Z08

ICPC

Social welfare problem

21.0

307.7

507

171

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

3.6

307.7

2016

4075

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

370.7

307.7

1074

N05AF03

ATC

chlorprothixene; systemic

291.6

307.7

655

R51.80

ICD-10 Finland

Headache

3.4

307.7

4836

11514

A01

ICPC

Pain general/multiple sites

3.7

307.7

2668

5489

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

+∞

307.7

786

N05AA02

ATC

levomepromazine; systemic

83.4

307.7

1115

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

+∞

307.7

6691

M79.0

ICD-10 Finland

Rheumatism, unspecified

9.6

307.7

1131

855

N06AB06

ATC

sertraline; oral

115.5

307.7

7436

636

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.9

307.7

3019

4691

N17

ICPC

Vertigo/dizziness

2.5

307.7

2728

8213

OAB93, ,

SPAT

6.7

307.7

3057

3512

N05AH04

ATC

quetiapine; oral

90.7

307.7

10721

1435

P58

ICPC

Psychological, Therapeutic counselling/listening

18.2

307.7

969

383

N06AA06

ATC

trimipramine; systemic

51.3

307.7

961

135

ZY010

NOMESCO Finland

Hospital outpatient

14.6

307.7

2613

1373

R4140

NOMESCO Finland

Psychotherapy

80.7

307.7

265

L02

ICPC

Back symptom/complaint

2.7

307.7

2823

7925

N76.0

ICD-10 Finland

Acute vaginitis

3.0

307.7

1883

4536

R07.4

ICD-10 Finland

Chest pain, unspecified

2.1

307.7

6049

23118

V03AA01, ,

ATC

23.5

307.7

391

117

C07AA05

ATC

propranolol; systemic

5.3

307.7

7038

12004

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

+∞

307.7

673

IHZ04, ,

SPAT

53.8

307.7

796

106

N06AX21

ATC

duloxetine; oral

38.6

307.7

7150

1787

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

297.2

307.7

1027

P06

ICPC

Sleep disturbance

7.3

307.7

5068

5851

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1587.9

307.7

1764

R11

ICD-10 Finland

Nausea and vomiting

3.3

307.7

2162

4844

F32.0

ICD-10 Finland

Mild depressive episode

+∞

307.7

1264

N02BF02

ATC

pregabalin; oral

5.2

307.7

2220

3206

P15

ICPC

Chronic alcohol abuse

39.7

307.7

1123

205

N03AX16

ATC

[U] pregabalin

4.1

307.7

6814

14558

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.3

307.7

1681

3735

F41

ICD-10 Finland

Other anxiety disorders

+∞

307.7

741

XA800

NOMESCO Finland

Neuropsychological investigation

4.7

307.7

1153

1749

E66.01

ICD-10 Finland

Obesity due to excess calories

3.3

307.7

3090

7185

N06BA12

ATC

lisdexamfetamine; oral

616.8

307.7

608

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

307.7

7882

31072

M79.7

ICD-10 Finland

Fibromyalgia

13.8

307.7

1509

804

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.7

307.7

3243

9032

N06AX11

ATC

mirtazapine; oral

34.8

307.7

15950

8512

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.7

307.7

2911

8132

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.4

307.7

6628

22922

M54

ICD-10 Finland

Dorsalgia

2.3

307.7

3158

10458

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.5

307.7

2925

8638

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.9

307.7

11805

55035

F99

ICD-10 Finland

Mental disorder, not otherwise specified

+∞

307.7

822

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.7

307.7

8013

25707

IGY99, ,

SPAT

18.9

307.7

839

318

R42

ICD-10 Finland

Dizziness and giddiness

2.4

307.7

5084

16733

H03AA01

ATC

levothyroxine sodium; systemic

2.2

307.7

5560

19903

N02BE01

ATC

paracetamol; systemic, rectal

2.6

307.7

21777

126968

F33

ICD-10 Finland

Recurrent depressive disorder

+∞

307.7

3719

SPAT1254

SPAT

Administration of medicine

2.5

307.7

2849

8547

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

340.4

307.7

1214

N05AB03

ATC

perphenazine; systemic, rectal

107.6

307.7

825

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

6.2

307.7

2194

2646

F32

ICD-10 Finland

Depressive episode

+∞

307.7

4272

L28

ICPC

Limited function/disability (L)

2.6

307.7

3665

10605

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

+∞

307.7

486

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

9.2

307.7

486

372

N06AG02

ATC

moclobemide; oral

73.2

307.7

2241

233

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

307.7

6656

22806

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

109.4

307.7

1691

115

AA400

NOMESCO Finland

Electroconvulsive therapy

1507.8

307.7

441

P01

ICPC

Feeling anxious/nervous/tense

23.3

307.7

7637

3226

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.6

307.7

3120

9159

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

+∞

307.7

454

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.3

307.7

1306

2174

ZYC02, ,

SPAT

6.5

307.7

1132

1248

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

+∞

307.7

373

N05CF01

ATC

zopiclone; oral

7.4

307.7

9975

14340

WZC00

NOMESCO Finland

Treatment plan or consultation

1.8

307.7

8944

41062

F43.01

ICD-10 Finland

Acute stress reaction moderate

+∞

307.7

598

P29

ICPC

Psychological sympt/compl other

22.3

307.7

3906

1432

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

+∞

307.7

441

N05AB01

ATC

dixyrazine; systemic

41.1

307.7

310

A06AC01

ATC

ispaghula (psylla seeds); oral

2.5

307.7

6144

20029

A02BC05

ATC

esomeprazole; systemic

2.1

307.7

9549

40138

F43.29

ICD-10 Finland

Adaptation disorder UNS

+∞

307.7

844

N05BA01

ATC

diazepam; systemic, rectal

8.4

307.7

4247

4110

F39

ICD-10 Finland

Unspecified mood [affective] disorder

+∞

307.7

786

N06AB03

ATC

fluoxetine; oral

48.6

307.7

6565

1265

N06AX03

ATC

mianserin; oral

70.5

307.7

2316

251

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

307.7

10218

36422

A05

ICPC

Feeling ill

3.1

307.7

1735

4081

N06DX01

ATC

memantine; oral

45.4

307.7

355

R74

ICPC

Upper respiratory infection acute

2.3

307.7

9882

39114

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

+∞

307.7

844

OAA81, ,

SPAT

4.2

307.7

1258

2180

N05BA06

ATC

lorazepam; systemic, sublingual

10.5

307.7

1189

822

L12

ICPC

Hand/finger symptom/complaint

2.1

307.7

4227

15572

A02BC01

ATC

omeprazole; systemic

2.1

307.7

5865

21722

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

7.2

307.7

1731

1763

N06AA10

ATC

nortriptyline; systemic

13.7

307.7

687

356

R02

ICPC

Shortness of breath/dyspnoea

2.8

307.7

3224

8707

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

192.5

307.7

1992

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

3.0

307.7

4327

11490

F45.8

ICD-10 Finland

Other somatoform disorders

+∞

307.7

2009

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

+∞

307.7

3371

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

14.5

307.7

740

363

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

260.4

307.7

2377

P02

ICPC

Acute stress reaction

8.3

307.7

2003

1801

ZY000

NOMESCO Finland

Hospital inpatient

47.3

307.7

436

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

+∞

307.7

757

F32.9

ICD-10 Finland

Depressive episode, unspecified

+∞

307.7

10967

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.1

307.7

1695

3963

N03AX09

ATC

lamotrigine; oral

30.0

307.7

1871

466

IHZ01, ,

SPAT

10.5

307.7

475

320

R52.2

ICD-10 Finland

Other chronic pain

6.0

307.7

1062

1276

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

+∞

307.7

9819

N04BC05

ATC

pramipexole; oral

3.7

307.7

1626

3183

N06AX22

ATC

agomelatine; oral

420.2

307.7

2056

SAA03

NOMESCO Finland

Extended examination of mouth

1.7

307.7

9788

47130

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

307.7

4481

15987

A03FA01

ATC

metoclopramide; systemic, rectal

2.0

307.7

4950

19334

F10.24

ICD-10 Finland

Alcohol depence active use

+∞

307.7

542

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

+∞

307.7

6405

N06AB08

ATC

fluvoxamine; oral

70.1

307.7

1129

117

N05AF01

ATC

flupentixol; systemic

44.1

307.7

499

Z2221

NOMESCO Finland

Medical doctor

2.0

307.7

6266

24694

Z2445

NOMESCO Finland

Psychologist

16.8

307.7

1782

788

IAA01, ,

SPAT

38.7

307.7

325

N05AH03

ATC

olanzapine; systemic

52.6

307.7

1954

279

G43

ICD-10 Finland

Migraine

3.3

307.7

1631

3559

N05BA04

ATC

oxazepam; oral

19.6

307.7

11660

7478

SPAT1283

SPAT

Restricted health certificate

2.5

307.7

5463

17237

A28

ICPC

Limited function/disability NOS

2.5

307.7

2533

7550

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

+∞

307.7

1316

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

26.5

307.7

325

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.5

307.7

2568

5472

M01AE02

ATC

naproxen; oral, rectal

1.9

307.7

13998

70332

N03AE01

ATC

clonazepam; systemic

10.2

307.7

1753

1270

L17

ICPC

Foot/toe symptom/complaint

2.0

307.7

7254

29043

R06AE07

ATC

cetirizine; oral

1.8

307.7

11036

52578

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

24.3

307.7

5552

2022

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

+∞

307.7

7615

F10.20

ICD-10 Finland

Alcohol dependence currently independent

+∞

307.7

842

F10.09

ICD-10 Finland

Alcohol intoxication UNS

+∞

307.7

647

H02AB06

ATC

prednisolone; systemic

1.7

307.7

10572

51314

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

307.7

3478

11487

R52.9

ICD-10 Finland

Pain, unspecified

2.6

307.7

2558

7362

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.7

307.7

2475

6731

IDY03, ,

SPAT

56.5

307.7

274

F60.8

ICD-10 Finland

Other specific personality disorders

+∞

307.7

386

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

8.5

305.7

476

395

J01EA01

ATC

trimethoprim; systemic

1.9

305.0

5338

21929

M01AE03

ATC

ketoprofen; systemic, rectal

1.7

305.0

7534

34371

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

3.5

304.5

1206

2460

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

5.3

304.0

724

979

J01CA08

ATC

pivmecillinam; oral

1.7

303.5

9135

44012

Z72.1

ICD-10 Finland

Alcohol use

16.1

303.3

328

143

SPAT1312

SPAT

General health counselling

1.8

303.3

7193

32423

F84.5

ICD-10 Finland

Asperger syndrome

+∞

302.2

335

N06DA02

ATC

donepezil; oral

23.0

301.4

285

SPAT1260

SPAT

Consultation of another employee

2.1

301.4

3654

13193

E66

ICD-10 Finland

Obesity

3.0

301.0

1590

3887

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

16.5

299.2

320

136

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.5

298.8

2285

6782

J45

ICD-10 Finland

Asthma

2.4

297.8

2569

8060

A03

ICPC

Fever

1.9

295.9

4500

17620

L08

ICPC

Shoulder symptom/complaint

1.9

294.4

5265

21748

R56.8

ICD-10 Finland

Other and unspecified convulsions

3.8

294.3

1060

2022

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

4.4

293.1

859

1397

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.4

289.2

1208

2553

H01

ICPC

Ear pain/earache

2.2

289.1

3076

10540

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.6

288.8

2024

5755

M01AH05

ATC

etoricoxib; oral

1.6

284.8

14977

82784

N07BA03

ATC

varenicline; oral

3.4

284.8

1207

2575

R03DC03

ATC

montelukast; oral

2.0

284.6

3952

14970

-1, ,

NOMESCO Finland

1.7

284.5

8042

37928

Z12

ICPC

Relationship problem with partner

6.8

284.4

530

553

P48

ICPC

Psychological, Clarification/discussion RFE/demand

29.2

283.7

250

F52.2

ICD-10 Finland

Failure of genital response

+∞

280.5

311

SFA30

NOMESCO Finland

Three-surface restoration

1.6

280.5

9974

49909

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

280.4

12565

66619

R01AD58

ATC

fluticasone, combinations; nasal

1.8

279.5

6503

29023

N05AD03

ATC

melperone; systemic

54.2

279.2

217

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

+∞

278.7

309

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

277.1

9779

48792

SPAT1235

SPAT

Mental health, emotional support

39.7

276.6

227

E0000UV, ,

ATC

1.6

276.5

9584

47595

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

7.6

276.1

469

437

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

276.0

4169

16246

K59.09

ICD-10 Finland

Constipation, unspecified

3.2

275.9

1265

2837

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

275.3

5538

23660

S29

ICPC

Skin symptom/complaint other

1.9

275.3

4546

18250

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

26.1

275.2

250

D06

ICPC

Abdominal pain localized other

2.4

274.9

2228

6784

S18

ICPC

Laceration/cut

1.6

274.8

10065

50663

IGV01

NOMESCO Finland

Psychiatric network contact

1107.8

274.1

309

J01DA01

ATC

[U] cefalexin

1.6

273.9

13976

76319

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.7

272.8

1744

4728

F06.7

ICD-10 Finland

Mild cognitive disorder

+∞

272.4

302

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

3.1

271.8

1326

3089

R03BA02

ATC

budesonide; inhalant

1.9

271.1

4086

15901

R01AD12

ATC

fluticasone furoate; nasal

1.7

270.9

7948

37748

IER01

NOMESCO Finland

Psychoeducation, group

+∞

269.6

299

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.0

269.5

3956

15253

A29

ICPC

General symptom/complaint other

2.2

269.0

2762

9312

A99

ICPC

Disease/condition unspecnature/site

2.3

267.4

2297

7176

IFB02

NOMESCO Finland

Transcranial magnetic stimulation (TMS)

+∞

266.0

295

UJF32

NOMESCO Finland

Coloscopy

1.8

265.2

5168

21832

F41.01

ICD-10 Finland

Severe panic disorder

+∞

265.1

294

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

265.0

2773

9419

J01AA02

ATC

doxycycline; systemic

1.7

264.4

17679

102829

K59.0

ICD-10 Finland

Constipation

3.4

264.3

1114

2366

Z06

ICPC

Unemployment problem

11.2

263.6

342

214

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.7

263.4

1637

4370

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

263.2

6279

28139

X59

ICD-10 Finland

Exposure to unspecified factor

1.9

263.0

4384

17624

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

14.7

263.0

296

141

ZXE10

NOMESCO Finland

More than one and less than three hours

1.7

261.8

7154

33274

SPAT1265

SPAT

Breathalyser

24.6

261.5

242

R83

ICPC

Respiratory infection other

1.7

261.2

6941

32036

D19

ICPC

Teeth/gum symptom/complaint

1.7

261.1

7779

37014

R01AD08

ATC

fluticasone; nasal

1.7

260.4

6731

30827

E66.9

ICD-10 Finland

Obesity, unspecified

3.6

259.7

973

1907

K59.1

ICD-10 Finland

Functional diarrhoea

3.1

259.6

1241

2854

X15

ICPC

Vaginal symptom/complaint other

3.4

259.2

1099

2343

L86

ICPC

Back syndrome with radiating pain

2.9

259.1

1443

3629

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

1972.1

257.3

288

M54.2

ICD-10 Finland

Cervicalgia

2.5

257.0

1896

5517

IEY01

NOMESCO Finland

Psychoeducation, individual

414.6

256.9

296

J01CA04

ATC

amoxicillin; systemic

1.8

256.1

20109

121536

F50.2

ICD-10 Finland

Bulimia nervosa

+∞

256.1

284

R4110

NOMESCO Finland

Physiotherapy

1.7

256.0

5828

25740

IGP01

NOMESCO Finland

Psychiatric family contact

61.6

254.2

194

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

7.1

253.2

453

450

U02

ICPC

Urinary frequency/urgency

2.0

252.9

3194

11651

SGA01

NOMESCO Finland

Emergency treatment

1.9

252.5

4225

16983

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.3

252.1

2170

6778

E66.00

ICD-10 Finland

Metabolic syndrome

2.9

251.7

1388

3470

F03

ICD-10 Finland

Unspecified dementia

+∞

250.7

278

D82

ICPC

Teeth/gum disease

1.6

250.3

9435

47504

R00.2

ICD-10 Finland

Palpitations

2.5

250.2

1905

5625

P18

ICPC

Medication abuse

69.1

250.0

188

L15

ICPC

Knee symptom/complaint

1.7

249.6

5706

25202

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

249.5

2493

8298

R03BB04

ATC

tiotropium bromide; inhalant

2.6

249.4

1680

4672

ZXE00

NOMESCO Finland

One hour or less

1.6

248.4

8186

39852

R06.5

ICD-10 Finland

Mouth breathing

2.3

248.0

2154

6753

ICB06, ,

NOMESCO Finland

+∞

247.9

275

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

+∞

247.9

275

K10.3

ICD-10 Finland

Alveolitis of jaws

3.0

247.7

1297

3147

N05CD02

ATC

nitrazepam; oral

14.1

247.4

284

141

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

252.2

245.9

289

K08.80

ICD-10 Finland

Toothache NOS

2.2

244.5

2320

7555

SCA01

NOMESCO Finland

Preventive oral health care, short

1.7

243.9

7157

33789

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

+∞

243.4

270

J01FA10

ATC

azithromycin; systemic

1.6

242.9

14154

78726

XF400

NOMESCO Finland

ECG with 12 standard connections

2.1

241.9

2659

9191

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

240.6

5979

26988

IHZ07, ,

SPAT

29.5

240.2

211

IBZ02

NOMESCO Finland

Somatic assessment of psychiatric patient

+∞

239.8

266

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.2

239.5

1116

2525

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

5.7

238.4

522

649

WZC00, ,

SPAT

1.9

236.2

3567

13831

IHZ05

NOMESCO Finland

Therapeutic conversation

33.4

236.0

201

K04.0

ICD-10 Finland

Pulpitis

2.2

236.0

2376

7925

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

234.8

5335

23462

N02CC07

ATC

frovatriptan; oral

3.2

234.8

1083

2434

ZYY01

NOMESCO Finland

Contact between professionals

107.3

234.7

169

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

+∞

234.4

260

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.3

234.1

2199

7124

TAB00

NOMESCO Finland

Lumbar puncture

3.3

232.0

995

2135

L16

ICPC

Ankle symptom/complaint

2.0

230.7

2838

10229

P28

ICPC

Limited function/disability (P)

41.0

230.6

188

G30.1

ICD-10 Finland

Alzheimer disease with late onset

13.1

229.6

274

147

R07.3

ICD-10 Finland

Other chest pain

2.2

228.7

2153

6979

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

+∞

228.1

253

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

227.5

4958

21522

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

2.0

226.3

3002

11116

OAA68, ,

SPAT

5.5

226.2

510

653

J01FA06

ATC

roxithromycin; oral

1.6

226.0

8437

42103

ZXD05

NOMESCO Finland

Urgent procedure

1.7

225.8

6213

28738

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.3

225.4

980

2121

SPAT1281

SPAT

Other administrative function

2.5

224.5

1656

4808

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

1710.3

223.9

251

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

223.6

2878

10539

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

+∞

223.5

248

NA1AD

NOMESCO Finland

Cervical spine CT examination

3.3

223.0

952

2036

SPAT1053

SPAT

Memory test

2.6

221.7

1505

4195

3007

Kela drug reimbursment

Erenumab and fremanezumab

6.8

221.3

408

420

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

205.0

220.4

262

K04.08

ICD-10 Finland

Other specified pulpit

2.2

219.8

2076

6734

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.4

219.2

1762

5325

Z50.4

ICD-10 Finland

Psychotherapy, not elsewhere classified

92.5

218.0

159

A11

ICPC

Chest pain NOS

2.4

217.9

1701

5071

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.6

217.7

1441

3965

WZB00, ,

SPAT

2.1

216.2

2553

9050

N02CC04

ATC

rizatriptan; oral

2.6

215.8

1443

3991

F60.7

ICD-10 Finland

Dependent personality disorder

+∞

215.4

239

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.2

215.0

2016

6517

F05.9

ICD-10 Finland

Delirium, unspecified

+∞

214.5

238

IDY99, ,

SPAT

44.5

214.2

172

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

213.7

7552

37081

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

+∞

213.6

237

D02

ICPC

Abdominal pain epigastric

2.5

213.3

1518

4329

M54.6

ICD-10 Finland

Pain in thoracic spine

2.4

213.2

1786

5497

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

+∞

212.7

236

T05

ICPC

Feeding problem of adult

10.5

212.6

287

192

R03BA05

ATC

fluticasone; inhalant

1.8

211.9

3985

16522

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2594

7905

2.42

321.76

3.2

4.0

4.48

4.60

pmol/l

5.77

2318

7342

(3026008) Bacteria identified in Urine by Culture

7396

33197

1.78

319.76

3.2

2.6

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3192

10812

2.20

310.13

2.9

2.5

37.22

42.90

u/l

1.28

2700

9319

(3001604) Monocytes [#/volume] in Blood

14212

66397

2.14

307.65

6.3

6.4

0.55

0.56

e9/l

5.18

12372

57818

(3037522) Nuclear Ab [Titer] in Serum

4926

18831

2.02

307.65

1.4

464.64

577.27

titre

3.78

953

4027

(40768797) Stomach Pathology biopsy report

4472

15839

2.17

307.65

1.3

1.2

—

(36304419) Bacteria [Presence] in Urine

7129

30821

1.85

307.65

3.4

2.9

45.00

131.67

estimate

0.34

122

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

5489

16498

2.68

307.65

2.5

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

6331

20109

2.59

307.65

1.7

1.6

25179889.17

46817342.88

pmol/l

2.10

5433

17216

(1001926) Buprenorphine [Presence] in Urine by Screen method

2704

3496

5.90

307.65

2.2

1.2

—

(3022096) Basophils/Leukocytes in Blood

12960

60934

2.00

307.65

6.5

6.6

0.70

0.68

12164

57704

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14220

63457

2.30

307.65

6.3

6.8

9.85

11.42

umol/l

58.29

13451

60788

(3020564) Creatinine [Moles/volume] in Serum or Plasma

24086

152700

4.55

307.65

20.9

15.0

72.48

74.82

umol/l

32.21

23916

150985

(3032080) INR in Blood by Coagulation assay

10684

52517

1.72

307.65

11.0

11.6

1.14

1.19

inr

14.14

8920

43232

(3021589) Normoblasts [#/volume] in Blood

11870

60255

1.70

307.65

11.1

10.0

0.00

e9/l

2.49

9643

49683

(3028300) Cannabinoids [Presence] in Urine

3119

5469

4.38

307.65

2.2

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

1878

4719

2.90

307.65

1.6

1.7

293.63

278.46

mu/l

0.80

1700

4370

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

9204

41654

1.85

307.65

3.7

3.2

3.11

1.98

e6/l

—

(3018010) Neutrophils/Leukocytes in Blood

13150

62008

2.00

307.65

6.3

6.4

56.12

56.51

3.73

12579

59798

(3022948) Iron [Moles/volume] in Serum or Plasma

5153

18717

2.15

307.65

2.4

2.7

14.03

13.85

umol/l

0.83

4787

17773

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

24040

152911

4.19

307.65

13.8

10.1

28.03

27.00

u/l

11.51

23662

149132

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

21904

130485

2.43

307.65

6.6

5.2

38.46

38.48

mmol/mol

0.10

20893

124106

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

5899

22886

2.03

307.65

1.4

1.3

7.65

12.72

u/ml

7.53

2330

9512

(3007164) IgA [Mass/volume] in Serum or Plasma

7379

26480

2.33

307.65

1.5

1.4

2.27

2.33

g/l

1.63

4592

17579

(46235355) HIV 1 and 2 tests - Meaningful Use set

7357

31173

1.91

307.65

2.3

1.9

—

(3027008) Opiates [Presence] in Urine

3109

5445

4.38

307.65

2.1

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

22548

132169

3.07

307.65

5.4

4.2

5.87

5.79

mmol/l

15.20

21370

123902

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

4348

15975

2.08

307.65

2.5

2.7

22.88

23.52

2.25

3998

15129

(3019309) Folate [Moles/volume] in Red Blood Cells

5246

12304

3.48

307.65

1.8

1.6

1136.92

1142.08

nmol/l

0.14

4175

9487

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5910

18318

2.63

307.65

2.6

1.9

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

13242

46544

3.09

307.65

2.3

1.8

98.57

97.45

pmol/l

1.80

7478

24442

(3019198) Lymphocytes [#/volume] in Blood

14545

68180

2.16

307.65

6.3

1.99

1.93

e9/l

3.97

12936

60755

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

7073

13123

4.83

307.65

2.0

1.4

1.48

1.25

124.88

6310

11895

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

13615

55400

2.57

307.65

6.8

7.4

1.21

mmol/l

0.22

11942

48317

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3646

10672

2.61

307.65

2.5

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

8446

37765

1.84

307.65

3.6

3.1

41.83

73.23

e6/l

2.75

6378

28271

(3013826) Glucose [Moles/volume] in Serum or Plasma

14802

72469

2.04

307.65

5.5

4.6

6.52

6.61

mmol/l

4.61

14015

67450

(36660697) Celiac disease serology panel - Serum

3130

10132

2.31

307.65

1.2

1.1

—

(3018095) Leukocytes [#/volume] in Urine

9840

45412

1.83

307.65

4.3

3.6

56.08

84.00

e6/l

5.39

6788

30547

(3023323) Follitropin [Units/volume] in Serum or Plasma

2634

7026

2.79

307.65

1.5

1.3

23.41

28.77

iu/l

12.45

2226

6122

(3001122) Ferritin [Mass/volume] in Serum or Plasma

15502

62108

2.96

307.65

3.7

2.9

91.80

117.51

ug/l

30.49

14659

59073

(3019550) Sodium [Moles/volume] in Serum or Plasma

23581

138871

4.79

307.65

18.7

13.3

139.63

139.81

mmol/l

29.20

23270

135841

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

3125

8612

2.74

307.65

2.3

1.8

—

(3019069) Monocytes/Leukocytes in Blood

12985

61025

2.00

307.65

6.5

6.6

8.43

8.77

36.98

12210

57937

(3037467) Urinalysis macro (dipstick) panel - Urine

17259

90240

2.08

307.65

4.9

3.9

35.91

2.40

0.48

146

(3028707) Methadone [Presence] in Urine by Screen method

2096

297

53.37

307.65

2.4

1.2

—

(3002030) Lymphocytes/Leukocytes in Blood

13317

63246

2.00

307.65

6.4

6.5

29.38

28.86

7.06

12654

60559

(3021601) Nitrite [Presence] in Urine by Test strip

13662

70493

1.77

307.65

4.0

3.3

0.00

estimate

0.10

2882

13665

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9432

42286

1.88

307.65

3.8

2.9

50.35

43.66

ng/l

0.21

5464

26092

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

11035

43161

2.40

307.65

3.6

3.2

31.92

32.95

u/l

0.29

10401

41109

(3011288) Drugs identified in Urine by Screen method Nominal

2820

2359

9.23

307.65

2.9

1.2

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

5649

19699

2.28

307.65

2.5

3.3

2.43

2.45

mmol/l

27.63

5024

17886

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

22601

135211

2.84

307.65

15.4

11.7

89.93

85.26

ml/min/173m2

220.44

21000

122552

(3013650) Neutrophils [#/volume] in Blood by Automated count

15458

74973

2.15

307.65

8.2

9.3

4.02

3.95

e9/l

3.63

13509

65260

(3027944) Amphetamines [Presence] in Urine

3020

5462

4.23

307.65

2.1

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

12189

51031

2.29

307.65

4.9

5.4

36.94

36.37

g/l

25.05

11471

48386

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

19650

98176

2.89

307.65

8.7

8.0

76.25

77.39

u/l

3.26

18790

93786

(3048689) Calprotectin [Mass/mass] in Stool

5336

16660

2.56

307.65

2.5

2.9

105.70

137.05

ug/g

10.07

4215

13668

(3023103) Potassium [Moles/volume] in Serum or Plasma

23586

139345

4.73

307.65

18.8

13.5

3.93

3.96

mmol/l

41.68

23241

135993

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

9525

36764

2.30

307.65

3.0

2.5

57.32

64.14

u/l

2.22

8830

34501

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

23360

125448

6.22

307.65

6.9

4.5

1.72

1.88

mu/l

81.62

22443

117402

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2896

2922

7.65

307.65

1.9

1.3

0.30

0.23

mg/l

7.45

1389

1242

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

781

127.06

307.65

1.7

1.5

—

(3018418) pH of Serum or Plasma

8353

32376

2.19

307.65

4.0

4.6

7.40

5.02

5873

22769

(3021960) Folate [Moles/volume] in Serum or Plasma

8962

25755

3.22

307.65

1.7

1.5

19.95

20.06

nmol/l

0.27

7918

22035

(3013115) Eosinophils [#/volume] in Blood

14579

68811

2.14

307.65

6.4

0.19

e9/l

1.05

12883

60798

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

8479

32959

2.19

307.65

2.4

2.0

209.80

185.02

u/l

0.56

8074

31292

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4744

18207

2.00

307.65

3.6

3.9

0.82

mmol/l

1.08

4480

17396

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

13820

56360

2.59

307.65

2.7

2.3

6438.41

76.95

nmol/l

0.50

12884

52409

(3009261) Glucose [Presence] in Urine by Test strip

13841

72023

1.75

307.65

4.1

3.3

0.02

0.16

estimate

0.76

2782

13252

(3015736) pH of Urine

11733

55389

1.89

307.65

3.5

3.0

6.21

6.17

3.86

6557

31831

(3044889) 12 lead EKG panel

16846

90744

1.90

307.65

3.9

3.4

0.41

3004.47

1.03

164

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

6356

24897

2.04

307.65

1.4

1.3

24.00

34.50

iu/ml

7.29

1703

7972

(3009508) Creatinine [Moles/volume] in Urine

9450

42373

1.88

307.65

3.5

3.4

8.00

7.97

mmol/l

0.21

8131

36900

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

19537

99075

2.75

307.65

4.3

2.7

45.85

41.93

u/l

7.18

18680

94730

(3006315) Basophils [#/volume] in Blood

14250

66521

2.14

307.65

6.3

6.4

0.04

e9/l

3.39

12408

57904

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

8544

30285

2.46

307.65

1.4

1.3

1.31

1.97

u/ml

5.25

2310

8803

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

6634

27422

1.93

307.65

1.9

1.8

0.92

1.19

mg/l

9.29

4923

21310

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4790

17318

2.14

307.65

2.4

2.7

2.46

2.38

g/l

17.10

4362

16308

(3015377) Calcium [Moles/volume] in Serum or Plasma

10227

37411

2.53

307.65

2.9

4.0

2.35

2.36

mmol/l

4.74

9416

34574

(3006504) Eosinophils/Leukocytes in Blood

12978

60879

2.01

307.65

6.4

6.6

2.87

2.88

0.32

12195

57736

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

23243

141000

3.37

307.65

17.4

11.8

19.73

23.65

mg/l

65.25

19606

110885

(4198724) Urine methamphetamine measurement

345

27.25

307.65

2.2

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

8123

27014

2.62

307.65

2.5

2.2

2.66

2.78

mg/l

5.07

7079

23729

(3031040) Bacteria [#/volume] in Urine by Automated count

16393

82914

2.10

307.65

5.2

3.7

1359.86

1479.54

e6/l

0.07

190

1048

(3000764) Benzodiazepines [Presence] in Urine

3108

5376

4.44

307.65

2.2

1.2

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

19447

96902

2.83

307.65

4.8

4.0

10.35

10.65

mm/h

2.58

18453

91720

(3030467) Casts [#/volume] in Urine by Automated count

7427

32196

1.86

307.65

3.4

3.0

0.28

0.38

e6/l

5.15

5386

22882

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

21832

102055

5.11

307.65

5.5

3.9

14.27

14.72

pmol/l

145.06

20622

94724

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4110

9594

3.36

307.65

2.1

2.5

367.55

380.61

nmol/l

3.43

3769

9052

(3035350) Ketones [Presence] in Urine by Test strip

13817

71331

1.78

307.65

4.0

3.3

4.00

3.46

estimate

0.14

2916

13909

(3016879) Cocaine [Presence] in Urine

3004

4786

4.82

307.65

2.2

1.2

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

12258

49036

2.45

307.65

6.4

6.7

1.21

mmol/l

3.29

11480

45856

(3020191) Ethanol [Moles/volume] in Serum or Plasma

488

421

8.18

304.69

1.8

1.1

1.65

0.79

promille

19.78

381

349

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

356

185

13.52

303.30

2.3

1.2

173.15

58.30

umol/l

5.87

198

(3000850) Epithelial cells [#/volume] in Urine

5866

25062

1.82

294.54

2.9

2.6

6.61

5.51

e6/l

5.23

5316

22848

(3019150) Specific gravity of Urine by Refractometry

6753

30166

1.76

291.51

3.9

3.3

1.02

1.12

kg/l

0.81

4291

19409

(3033658) Prothrombin time (PT) actual/Normal

6964

31643

1.73

281.33

4.6

3.8

95.74

92.35

26.36

6763

30996

(3017143) Hepatitis C virus Ab [Presence] in Serum

4473

17766

1.91

280.32

1.8

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3722

14004

1.99

272.10

5.7

7.1

1.04

mmol/l

0.11

3492

13151

(3009214) Lutropin [Units/volume] in Serum or Plasma

1558

4054

2.78

263.02

1.5

1.4

9.35

9.93

u/l

0.84

1228

3377

(3026782) Osmolality of Urine

4963

20864

1.81

257.85

3.0

2.8

520.25

546.58

mosm/kgh2o

11.55

4357

18458

(3023368) Bacteria identified in Blood by Culture

6473

29439

1.71

256.13

4.5

4.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2825

9791

2.13

256.09

1.3

1.2

117.68

160.45

u/ml

6.90

1016

3970

(3013512) EKG study

8186

39741

1.64

252.00

3.5

3.1

0.74

0.02

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2929

10375

2.09

250.67

2.5

2.4

0.22

g/l

5.10

2691

9879

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1216

2829

3.08

249.43

1.4

282.64

279.52

ug/g

0.13

664

1661

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2028

6256

2.36

241.90

3.2

3.4

5.17

5.09

kpa

5.15

1947

6003

(3009343) pH of Capillary blood

1980

6055

2.38

240.73

3.2

3.4

7.41

7.42

2.68

1657

4990

(3007853) Bacteria identified in Skin by Aerobe culture

3550

13676

1.93

239.97

1.8

1.6

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3582

13845

1.93

239.77

2.9

6.51

8.46

umol/l

7.83

3005

12400

(40758558) Short blood count panel - Blood

7954

38794

1.62

236.86

5.8

6.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4052

16554

1.83

227.71

2.0

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2130

6896

2.25

226.84

1.1

1.0

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2214

7299

2.21

225.75

1.7

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4724

20281

1.76

224.86

3.0

2.7

0.95

1.01

e6/l

0.48

2399

10526

(3019225) pH of Specimen

2692

9616

2.06

223.78

3.8

4.2

7.35

7.36

0.11

2010

7014

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1736

5177

2.43

222.35

3.0

3.2

1.45

1.60

mmol/l

1.05

1272

3744

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2970

11061

1.98

219.89

2.9

2.1

12.65

13.62

nmol/l

8.17

2677

10416

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1044

2409

3.09

216.63

1.3

459.88

555.93

mg/l

4.55

1000

2324

(3023511) Choriogonadotropin [Units/volume] in Urine

1023

2336

3.12

215.94

1.4

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

7558

37128

1.59

213.35

4.3

3.5

0.00

estimate

1.18

2748

12722

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4356

18558

1.76

211.35

3.1

2.8

3.69

2.89

e6/l

2.80

2010

8790

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

1337

3632

2.64

206.90

2.1

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

949

2131

3.17

205.73

1.4

1.5

944.78

1455.55

e6/l

0.83

730

1650

(3005322) IgE [Units/volume] in Serum or Plasma

2538

9141

2.03

205.35

1.4

1.3

264.84

238.83

u/ml

0.27

2375

8588

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

946

2129

3.16

204.33

1.2

1.3

3.78

3.64

mmol/l

2.92

894

2023

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1849

5894

2.27

203.40

2.4

4970.47

6355.11

u/l

1.11

634

2745

(3025941) Bacteria identified in Stool by Culture

2048

6824

2.18

202.56

1.3

1.2

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

932

2095

3.17

201.66

1.4

28.21

39.78

e6/l

0.48

678

1528

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

10256

54536

1.52

199.84

3.9

3.2

0.73

0.37

estimate

0.45

2414

11243

(3003327) Ova and parasites identified in Stool by Light microscopy

1543

4582

2.42

198.82

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1520

4525

2.42

194.70

2.1

1.7

37.39

40.98

nmol/l

6.27

1489

4460

(3011397) Hemoglobin [Presence] in Urine by Test strip

6430

30932

1.60

194.48

4.0

3.3

0.79

0.32

1.01

304

(3022145) Colonoscopy Study observation

3578

14759

1.80

191.74

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1892

6239

2.19

191.56

1.1

11.69

4.80

u/ml

0.28

(3013139) Helicobacter pylori Ag [Presence] in Stool

2378

8582

2.02

190.60

1.3

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1198

3221

2.66

188.82

2.2

1.7

200.49

205.00

pmol/l

0.61

1119

3118

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

2481

9131

1.98

188.18

1.5

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

850

1904

3.17

184.80

1.4

1.3

25.35

28.83

u/l

1.91

673

1637

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

690

1360

3.59

182.18

1.5

1.8

336.85

352.99

mu/l

0.26

534

1144

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1186

3245

2.61

180.52

3.2

3.4

24.83

24.71

mmol/l

0.85

1110

3013

(3023183) Ammonium ion [Moles/volume] in Plasma

739

1549

3.38

178.19

3.1

2.8

35.17

34.94

umol/l

0.05

676

1427

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6219

30191

1.57

178.06

3.0

788.41

1053.89

ng/l

7.36

5028

25913

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4681

21258

1.65

175.96

3.9

3.3

285.63

644.32

ng/l

5.76

2980

15388

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2962

11886

1.83

172.23

1.9

1.7

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1865

6402

2.10

169.98

1.1

154.20

196.49

titre

0.35

234

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

242

177

9.56

169.41

1.0

1.1

31.55

28.90

ng/l

0.52

170

123

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2607

10097

1.88

169.23

4.2

4.0

5.88

5.80

kpa

3.83

2540

9886

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3058

12467

1.80

168.62

6.6

5.4

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1537

4897

2.25

168.31

1.3

0.41

0.97

u/ml

2.15

119

364

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

241

177

9.52

168.26

1.0

1.1

922.89

871.08

ng/l

0.49

163

125

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

241

177

9.52

168.26

1.0

1.1

246.37

438.52

ng/l

0.46

171

128

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2444

9305

1.91

166.94

2.5

2.4

18.47

20.87

au/ml

0.87

251

1256

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

19846

123319

1.59

166.66

19.8

14.3

13.45

13.43

1.86

19630

121564

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

22654

145924

1.91

165.42

5.8

5.0

2.83

2.84

mmol/l

1.18

21537

138789

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2294

8579

1.94

165.09

1.3

49.07

52.96

au/ml

0.31

107

604

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

720

1561

3.26

164.73

1.7

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

2440

9371

1.89

162.11

7.9

8.8

1.34

1.27

mmol/l

2.02

2384

9227

(3005719) IgG [Mass/volume] in Serum or Plasma

2543

9930

1.86

160.48

2.5

3.0

10.38

10.66

g/l

2.97

2317

9285

(3002032) Base excess in Venous blood by calculation

2531

9899

1.86

158.83

4.2

4.0

1.72

1.75

mmol/l

0.15

2255

8810

(3024354) Oxygen [Partial pressure] in Venous blood

2199

8238

1.93

157.08

3.6

3.2

4.70

4.65

kpa

0.50

2134

8046

(3012544) pH of Venous blood

2612

10355

1.84

156.96

4.2

4.1

7.37

7.38

2.20

1437

5992

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

21437

136250

1.68

156.67

4.4

3.8

1.41

1.25

mmol/l

126.78

20172

128923

(3009466) Valproate [Moles/volume] in Serum or Plasma

318

365

6.11

156.64

3.0

2.9

322.95

374.64

umol/l

5.00

259

304

(3044290) Cell count panel - Cerebral spinal fluid

839

2059

2.89

156.16

1.3

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2782

11294

1.80

154.64

1.9

1.7

—

(3007461) Platelets [#/volume] in Blood

24336

161981

3.57

153.03

26.2

17.4

265.70

254.04

e9/l

151.74

24059

158625

(3000494) Fungus identified in Specimen by Culture

3566

15606

1.68

151.99

1.6

1.4

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

24340

162115

3.55

150.25

26.1

17.3

90.52

90.41

3.45

24209

160662

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

22448

144818

1.81

150.24

5.3

4.5

4.73

4.78

mmol/l

10.01

21401

138344

(3035941) MCH [Entitic mass]

24340

162118

3.55

150.16

26.0

17.3

30.20

30.18

1.52

24209

160670

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

24340

162132

3.54

149.74

26.7

17.7

40.98

41.93

3.59

24204

160570

(3026361) Erythrocytes [#/volume] in Blood

24340

162149

3.53

149.22

26.1

17.4

4.54

4.58

e12/l

28.53

24008

158300

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5602

27487

1.53

148.26

1.7

—

(3010813) Leukocytes [#/volume] in Blood

24341

162193

3.53

148.21

26.2

17.4

6.74

6.54

e9/l

39.09

24020

158320

(3019832) Treponema pallidum Ab [Presence] in Serum

4113

18799

1.62

147.63

2.0

1.8

—

(3014051) Protein [Presence] in Urine by Test strip

7675

40219

1.47

147.61

2.9

2.6

0.25

0.04

1.53

106

780

(3000963) Hemoglobin [Mass/volume] in Blood

24341

162228

3.51

147.15

26.3

17.5

136.32

137.45

g/l

32.63

24212

160789

(3042936) Bacteria identified in Isolate by Culture

3776

16926

1.65

146.31

2.3

1.9

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

22344

144176

1.77

145.03

5.2

4.4

1.42

1.49

mmol/l

114.07

21225

137153

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1679

5888

2.05

143.85

4.2

4.4

24.30

24.23

mmol/l

0.42

1648

5842

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1432

4731

2.17

143.07

1.6

1.7

13.28

15.46

u/ml

0.55

315

1377

(3041096) Erythrocytes [Presence] in Urine by Automated

7611

40007

1.46

142.99

3.3

2.8

0.05

0.21

estimate

1.93

2398

10898

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1614

5664

2.04

137.84

1.7

3.77

4.23

mg/l

0.98

1354

3827

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1072

3218

2.37

133.86

2.2

2.5

300.88

591.92

ug/l

2.00

997

3038

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1557

5456

2.04

133.37

1.8

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

6660

34495

1.46

132.90

2.5

2.6

324.38

336.55

umol/l

19.90

5911

31505

(3017732) Neutrophils [#/volume] in Blood

3641

16532

1.62

132.79

2.7

2.9

4.31

4.30

e9/l

0.01

3122

14750

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2093

8153

1.85

131.77

3.6

4.0

1.23

mmol/l

1.80

1759

7184

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6245

31998

1.47

131.40

2.5

2.2

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3763

17299

1.60

130.18

2.2

2.3

29.23

29.49

1.99

3656

16876

(3014765) Yersinia sp identified in Stool by Organism specific culture

1010

3007

2.39

128.35

1.2

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

1012

3018

2.38

128.13

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1986

7681

1.86

127.70

1.7

1.6

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1004

2999

2.38

126.64

1.2

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

11293

64679

1.39

126.32

2.9

2.6

—

estimate

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

822

2259

2.58

123.45

1.6

1.5

0.39

0.44

nmol/l

0.60

614

1782

(3028026) IgM [Mass/volume] in Serum or Plasma

1964

7698

1.84

120.81

1.9

1.26

1.30

g/l

0.34

1801

7202

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10564

60387

1.37

115.81

2.0

1.8

1.51

1.33

mmol/l

63.96

9045

52154

(3027945) Reticulocytes/Erythrocytes in Blood

2676

11611

1.67

115.35

2.4

2.8

1.79

1.75

1.03

2350

10629

(3020682) Albumin/Creatinine [Ratio] in Urine

7449

40240

1.41

114.36

4.3

4.2

7.85

7.76

mg/mmol

0.06

4614

24953

(3012516) Albumin [Mass/volume] in Urine

7350

39699

1.40

112.51

3.6

44.99

45.30

mg/l

0.04

4693

24860

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1039

3353

2.20

109.42

2.6

2.8

24.59

24.48

mmol/l

0.46

1020

3300

(3008898) HLA-B27 [Presence]

1415

5143

1.96

108.95

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

266

370

5.03

108.27

1.3

137.47

134.25

nmol/l

0.44

266

370

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2781

12415

1.62

106.71

1.5

—

(3045414) Leukocytes [Presence] in Urine

2639

11655

1.64

105.63

2.1

2.0

0.05

0.03

estimate

0.72

558

2641

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1009

3267

2.19

105.36

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2000

8205

1.75

105.11

3.5

4.4

79.59

90.16

ng/l

5.83

1739

7328

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

410

827

3.48

104.57

1.6

2.3

19.62

18.86

nmol/l

0.80

379

792

(3023410) Appearance of Cerebral spinal fluid

456

989

3.24

104.15

1.5

1.6

—

(3023420) DNA double strand Ab [Units/volume] in Serum

1498

5689

1.88

101.10

1.9

7.35

7.53

iu/ml

0.06

352

1335

(3027801) Oxygen [Partial pressure] in Arterial blood

2683

12080

1.61

98.95

8.5

12.26

13.38

kpa

22.58

2596

11653

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2682

12082

1.60

98.67

8.5

5.12

5.08

kpa

1.45

2596

11659

(3000492) Spirometry study

3162

14830

1.55

97.80

1.6

1.5

—

21.97

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1766

7154

1.77

96.62

8.1

9.1

24.93

24.74

mmol/l

1.39

1750

7116

(3019977) pH of Arterial blood

2675

12115

1.60

96.09

8.6

8.5

7.41

7.42

1.56

1467

6280

(3003396) Base excess in Arterial blood by calculation

2641

12017

1.59

92.82

8.6

8.4

0.83

0.75

mmol/l

0.47

2212

9960

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1363

5198

1.87

90.57

1.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

475

1153

2.89

89.96

1.3

1.2

27.43

30.14

nmol/l

—

(3007566) Smooth muscle Ab [Titer] in Serum

1062

3753

2.01

88.15

1.3

72.67

137.08

titre

3.05

373

(1616796) Gas panel - Central venous blood

689

2069

2.35

85.64

3.0

3.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

+∞

85.52

1.5

0.0

567.56

—

nmol/l

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1127

4114

1.94

85.29

1.3

30.34

48.63

u/ml

1.50

245

(3034770) Mitochondria Ab [Titer] in Serum

1044

3710

1.99

85.29

1.2

1.3

590.00

1170.33

titre

1.23

120

(3004716) Salmonella sp identified in Stool by Organism specific culture

1704

7083

1.72

84.82

1.3

1.5

—

(3016502) Oxygen saturation in Arterial blood

2366

10721

1.59

84.14

9.0

95.56

96.12

3.87

2308

10344

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3079

14820

1.50

83.39

4.8

4.4

30.32

32.26

19.18

2318

10301

(3020779) Urea [Moles/volume] in Serum or Plasma

2171

9661

1.61

83.19

7.8

9.3

8.00

9.28

mmol/l

16.23

2081

9323

(3023520) Reticulocytes [#/volume] in Blood

1994

8714

1.64

82.12

2.4

2.9

73.95

70.50

e9/l

3.13

1409

6387

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1857

8019

1.65

80.04

2.4

2.1

6.55

8.91

ug/l

3.11

1573

7283

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

451

1136

2.79

79.95

1.1

113.40

73.01

au/ml

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

815

2707

2.12

79.66

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

349

760

3.22

79.26

3.6

3.1

32.26

23.91

mu/l

3.03

326

719

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

596

1753

2.39

77.53

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

596

1753

2.39

77.53

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

2163

9785

1.58

77.12

4.0

3.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1308

5196

1.79

75.95

1.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1545

6449

1.71

75.49

3.6

3.3

132.90

130.58

g/l

3.60

1504

6301

(3003181) Sodium [Moles/volume] in Urine

508

1412

2.53

74.46

1.5

1.3

57.44

63.28

mmol/l

2.19

383

1142

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1076

4047

1.88

74.36

1.9

1.8

0.23

g/l

0.19

1036

3877

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1099

4166

1.87

74.14

1.9

1.8

1.22

1.19

g/l

3.61

1060

4010

(3020891) Body temperature

1153

4487

1.82

71.55

5.1

4.2

36.94

36.89

°c

3.11

1146

4458

(3002179) Metamyelocytes/Leukocytes in Blood

2297

10728

1.53

70.87

3.7

4.5

0.56

0.74

2.67

614

3160

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1035

3905

1.87

70.80

1.3

4.89

6.95

u/ml

0.40

397

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1033

3899

1.87

70.57

1.3

5.55

9.18

u/ml

1.08

133

593

(3025159) Blasts/Leukocytes in Blood

2338

10973

1.53

70.52

4.1

4.8

0.06

0.44

4.77

507

2821

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

546

1612

2.38

70.45

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

863

3068

1.98

70.29

1.2

1.3

36.72

49.72

u/ml

1.12

296

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

976

3626

1.90

69.96

1.1

2.72

6.20

eliau/ml

4.39

142

538

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

394

992

2.78

69.93

1.2

1.1

38.48

47.49

mg/l

2.75

335

852

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

316

703

3.14

69.40

1.4

1.2

5.32

5.67

umol/l

0.65

267

632

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1268

5130

1.75

69.07

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

698

2311

2.13

68.74

2.9

3.0

8.56

8.46

kpa

0.87

679

2258

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1492

6340

1.67

68.04

10.0

11.0

24.22

24.21

mmol/l

0.02

1458

6255

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1277

5218

1.73

67.16

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

532

1590

2.35

66.82

2.1

1.9

3721.48

2731.73

titre

0.31

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

380

965

2.76

66.41

1.1

257.79

267.72

mg/l

0.25

336

865

(3010421) pH of Blood

860

3122

1.94

65.96

3.2

7.41

1.81

846

3086

(3021440) Promyelocytes/Leukocytes in Blood

2288

10838

1.51

65.86

3.9

4.7

0.10

0.13

0.66

542

2874

(3017181) Myelocytes/Leukocytes in Blood

2362

11287

1.50

65.16

3.9

4.7

0.76

0.97

3.05

617

3314

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

406

1080

2.63

64.98

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

819

2952

1.96

64.12

2.9

1.84

2.55

index

2.08

411

1437

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2178

10273

1.52

63.87

9.7

9.4

124.07

122.04

g/l

4.41

2141

10027

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

952

3615

1.86

63.77

1.2

4.42

3.89

0.50

140

649

(3012501) Base excess in Blood by calculation

604

1945

2.18

63.74

3.3

3.4

2.38

2.40

mmol/l

0.05

407

1295

(3013290) Carbon dioxide [Partial pressure] in Blood

604

1946

2.18

63.66

3.3

3.4

5.04

4.96

kpa

1.77

588

1906

(3041806) Other cells [#/volume] in Blood by Manual count

245

489

3.50

63.60

1.5

1.3

0.51

0.54

e9/l

0.81

245

489

(3027315) Oxygen [Partial pressure] in Blood

609

1970

2.17

63.56

3.4

8.99

8.85

kpa

1.06

593

1930

(3026389) Candida sp identified in Specimen by Organism specific culture

538

1660

2.28

62.86

1.4

1.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

356

900

2.77

62.75

1.1

—

(3024928) Oxygen saturation in Venous blood

742

2603

2.01

62.68

3.6

3.7

62.42

64.27

1.32

709

2558

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1365

5793

1.67

62.42

2.1

2.3

40.26

40.01

u/l

0.16

1232

5291

(3020630) Protein [Mass/volume] in Serum or Plasma

1880

8646

1.55

61.80

2.3

2.9

66.91

66.80

g/l

0.24

1719

8144

(4027681) Cerebrospinal fluid IgG ratio and IgG index

311

745

2.92

60.39

1.2

0.66

0.68

ratio

0.10

187

431

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1528

6756

1.61

59.37

10.9

11.2

0.64

0.20

1522

6730

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1567

6973

1.60

59.29

10.7

10.9

1.40

1.23

8.87

1559

6941

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

982

3873

1.79

58.18

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

263

583

3.15

58.17

1.1

1.59

8.12

nmol/l

1.48

118

(3013005) Retinol [Moles/volume] in Serum or Plasma

244

517

3.30

57.95

1.8

1.96

1.95

umol/l

0.01

217

474

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

909

3510

1.83

57.71

1.1

1.99

2.56

u/ml

0.87

488

1862

(3020717) Zinc [Moles/volume] in Serum or Plasma

277

637

3.04

57.69

1.6

1.5

20.58

26.23

umol/l

2.27

255

595

(3003129) Base excess in Capillary blood by calculation

412

1174

2.46

57.42

1.9

2.2

0.67

0.31

mmol/l

1.07

396

1125

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

323

814

2.77

57.30

1.3

—

(3019060) Gas panel - Arterial blood

1308

5625

1.65

56.74

5.4

4.9

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

460

1389

2.32

56.50

1.4

1.5

—

(3045424) Erythrocytes [Presence] in Urine

1390

6079

1.62

56.40

2.1

0.03

0.18

estimate

0.68

451

2139

(3008295) Osmolality of Serum or Plasma

334

866

2.70

56.21

1.6

1.4

278.48

279.99

mosm/kgh2o

0.56

245

705

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

466

1421

2.30

55.98

1.4

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

318

806

2.76

55.84

1.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2256

11003

1.46

55.75

3.6

2.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

353

949

2.60

55.40

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

441

1326

2.33

54.70

1.3

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

441

1327

2.33

54.60

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

457

1400

2.29

54.33

1.4

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

439

1322

2.33

54.26

1.3

1.5

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

913

3597

1.79

54.26

1.1

—

(3021901) Oxygen saturation in Capillary blood

577

1947

2.08

54.12

2.7

3.0

91.47

91.08

0.93

563

1896

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1168

4945

1.67

53.76

4.2

3.6

49.86

47.17

2.95

1156

4880

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

525

1713

2.15

53.66

1.2

1.4

0.13

0.23

nmol/l

2.21

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

951

3829

1.75

52.49

2.0

2.1

14.45

12.52

iu/l

0.07

367

1674

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

842

3271

1.81

52.40

1.2

1.3

1.55

5.55

u/ml

1.90

242

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

860

3364

1.80

52.32

1.3

23.82

16.17

u/ml

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1990

9583

1.48

52.30

2.5

2.4

0.38

0.34

e6/l

0.42

1904

9083

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1272

5562

1.62

51.56

1.4

1.3

242.41

222.46

miu/ml

1.00

562

2802

(44813793) Dust mix specific IgE antibody measurement

340

936

2.54

50.93

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

794

3058

1.83

50.80

1.1

5.30

5.54

u/ml

0.15

440

1637

(3024980) IgG subclass 4 [Mass/volume] in Serum

638

2302

1.95

49.79

1.5

1.6

0.71

0.80

g/l

1.48

500

1809

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

505

1686

2.10

48.72

1.3

1.4

0.57

2.01

nmol/l

0.93

482

1633

(3008401) Mugwort IgE Ab [Units/volume] in Serum

760

2932

1.82

48.36

1.1

1.18

1.13

u/ml

0.07

343

1296

(3025130) Human papilloma virus identified in Specimen

670

2492

1.89

47.79

1.8

1.9

—

(3018405) Lactate [Moles/volume] in Arterial blood

765

2977

1.81

47.33

4.6

4.0

1.32

mmol/l

0.01

759

2920

(3022621) pH of Urine by Test strip

2116

10503

1.43

47.29

2.4

2.2

6.08

6.07

0.06

1283

6814

(3010726) Horse dander IgE Ab [Units/volume] in Serum

754

2927

1.81

47.02

1.1

2.09

1.70

u/ml

0.57

400

1417

(3020911) Cortisol [Moles/time] in 24 hour Urine

184

374

3.43

46.64

1.5

1.4

226.67

250.62

nmol/24h

0.05

184

374

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

2103

10455

1.43

46.56

2.5

2.6

75.02

69.20

ml/min/173m2

8.57

886

4124

(40767503) Oxygen content in Capillary blood by calculation

563

1993

1.98

46.40

2.5

2.4

17.21

16.88

1.73

548

1948

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

273

705

2.70

46.38

1.5

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2599

13418

1.38

46.31

3.8

5.4

225.47

245.40

u/l

10.60

2450

12943

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

321

903

2.48

46.04

1.2

—

(3036489) Thrombin time

1158

5116

1.60

44.91

2.2

2.3

20.50

20.92

1.47

1016

4483

(3016650) Hepatitis A virus Ab [Presence] in Serum

610

2253

1.90

44.45

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

984

4194

1.65

44.06

2.0

1.9

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

230

557

2.88

43.95

1.5

1.7

1.93

8.34

nmol/l

0.89

167

476

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

614

2283

1.89

43.85

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

901

3781

1.68

42.80

2.0

1.7

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

202

463

3.04

42.44

1.9

1.8

28.64

29.57

umol/l

0.58

186

436

(3006270) Folate [Moles/volume] in Blood

259

683

2.65

42.32

1.2

1.1

394.47

370.95

nmol/l

0.97

237

602

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1075

4736

1.60

42.15

1.7

1.9

1.50

1.48

g/l

0.26

934

4111

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

736

2937

1.76

41.87

2.1

2.4

0.00

g/l

0.00

639

2631

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

432

1445

2.09

41.53

1.3

1.4

0.17

0.37

nmol/l

0.64

304

1141

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

463

1598

2.03

40.96

1.2

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

415

1378

2.11

40.66

1.3

1.4

2.96

3.06

g/l

0.56

303

1003

(3024139) IgG subclass 3 [Mass/volume] in Serum

415

1378

2.11

40.66

1.3

1.4

0.34

0.43

g/l

4.28

304

1000

(3029634) Reagin Ab [Titer] in Serum by VDRL

560

2076

1.89

40.38

2.4

2.3

15.06

5.95

titre

0.65

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1040

4593

1.60

40.35

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

141

264

3.72

40.26

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

259

701

2.58

40.24

1.1

1.10

1.19

u/l

0.62

100

289

(3028271) Lactate [Moles/volume] in Capillary blood

419

1403

2.09

40.18

1.8

1.6

1.80

1.68

mmol/l

1.26

406

1358

(3027135) IgG subclass 1 [Mass/volume] in Serum

414

1381

2.10

40.10

1.3

1.4

6.38

6.98

g/l

2.57

301

1004

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

168

356

3.29

40.06

1.5

2.6

0.77

1.08

ug/l

1.05

157

338

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

9.43

39.83

1.1

1.2

46.53

39.78

mg/l

0.81

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

249

665

2.61

39.73

1.3

1.6

6.41

5.90

u/l

0.18

205

574

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1174

5355

1.55

39.62

1.3

1.7

4.42

14.85

iu/ml

5.91

200

(3019420) Tryptase [Mass/volume] in Serum or Plasma

273

766

2.49

39.44

1.4

1.6

6.41

7.55

ug/l

1.52

249

700

(3027273) Bicarbonate [Moles/volume] in Venous blood

1023

4526

1.59

39.39

3.7

3.4

25.35

25.36

mmol/l

0.06

995

4380

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

519

1893

1.92

39.29

1.2

15.77

18.96

u/ml

0.13

(3037121) Protein [Mass/volume] in Urine

904

3885

1.64

39.17

3.2

3.6

333.16

425.95

mg/l

0.85

366

1900

(4062490) Immunoglobulin typing, IgG

406

1357

2.09

39.13

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

281

806

2.43

38.77

1.2

1.88

2.11

mmol/l

2.67

262

755

(3014133) Dog dander IgE Ab [Units/volume] in Serum

662

2620

1.77

38.74

1.1

4.76

3.42

u/ml

0.98

338

1294

(3006184) Hemoglobin [Mass/volume] in Capillary blood

641

2513

1.79

38.72

2.1

134.74

132.07

g/l

1.86

477

1896

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

364

1171

2.17

38.64

2.1

1.9

21.67

23.97

mg/l

0.40

140

458

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

188

438

2.99

38.48

1.3

1.5

73.61

71.63

0.97

180

426

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

840

3568

1.65

38.10

2.2

2.5

0.54

0.72

g/l

0.88

738

3174

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

326

1011

2.25

37.80

1.3

1.91

2.03

u/ml

0.06

181

584

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

161

345

3.25

37.76

1.4

1.5

13.05

15.63

pmol/l

3.57

134

300

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

184

430

2.98

37.48

1.3

1.5

430.93

540.51

mu/l

0.68

176

418

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

747

3090

1.70

37.43

2.1

2.3

0.02

g/l

0.39

673

2837

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

19495

128724

1.24

37.15

21.1

14.3

333.02

333.01

g/l

0.05

19413

127975

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

219

567

2.69

37.13

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

214

548

2.72

37.04

1.1

—

(3011985) Renin [Units/volume] in Plasma

501

1855

1.89

36.30

1.7

1.6

76.24

58.04

mu/l

0.84

440

1689

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

104

170

4.26

35.47

1.4

1.8

1.21

1.07

nmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

618

2463

1.76

35.34

1.1

6.09

4.31

u/ml

0.67

292

1100

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1303

6228

1.48

35.18

8.2

6.7

24.55

24.48

mmol/l

0.30

1265

5932

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

900

3970

1.59

35.08

2.1

2.4

2.83

2.86

g/l

0.54

823

3719

(3022806) Fractional oxyhemoglobin in Capillary blood

335

1089

2.15

34.71

1.8

1.6

90.56

90.69

0.18

327

1070

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

674

2769

1.71

34.64

2.2

2.4

0.00

g/l

-0.00

634

2630

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

311

987

2.20

34.19

1.1

289.40

289.74

mg/l

0.02

276

920

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

330

1073

2.15

34.18

1.1

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

936

4203

1.57

33.82

2.1

2.4

7.20

7.29

g/l

0.83

859

3953

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

935

4199

1.57

33.76

2.1

2.4

4.23

4.25

g/l

0.17

859

3949

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

500

1897

1.84

33.63

1.1

1.48

g/l

0.14

457

1749

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

620

2514

1.73

33.40

1.1

25.16

13.12

au/ml

1.92

153

810

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

932

4194

1.56

33.36

2.1

2.4

3.69

3.70

g/l

0.06

858

3944

(3016038) Potassium [Moles/volume] in Urine

204

539

2.64

33.33

1.4

1.2

33.96

36.06

mmol/l

0.53

170

490

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

131

270

3.38

32.68

1.4

1.2

111.64

129.04

nmol/l

0.77

203

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

460

1716

1.88

32.62

1.4

334.61

382.22

pmol/l

0.34

394

1487

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

285

891

2.23

32.50

1.2

1.1

0.96

1.07

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

816

3584

1.60

32.39

2.1

2.4

9.71

10.29

g/l

3.70

731

3304

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

918

4157

1.55

31.96

2.7

182.84

187.94

0.95

877

3977

(3004616) Nuclear Ab [Presence] in Serum

442

1649

1.87

31.35

1.3

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

756

3286

1.61

31.32

1.2

1.3

27.28

41.53

u/ml

1.25

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

178

453

2.74

31.26

1.2

1.3

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

850

3807

1.57

31.06

2.2

2.4

11.10

11.21

mg/l

0.16

804

3603

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

713

3061

1.63

31.04

1.2

1.3

269.74

257.01

u/ml

0.53

453

1999

(3038177) Helicobacter pylori Ab [Presence] in Serum

581

2377

1.71

30.35

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

199

546

2.54

30.23

1.1

11.81

11.03

u/ml

0.10

110

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

185

493

2.61

29.78

1.1

—

(3036180) Methadone [Presence] in Urine

+∞

29.69

2.1

0.0

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

+∞

29.69

1.3

0.0

156.31

—

nmol/l

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

130

284

3.19

29.69

1.2

1.3

20.00

18.41

0.06

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

135

302

3.11

29.68

2.3

2.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

181

480

2.63

29.42

1.1

1.3

70.36

70.78

0.02

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

546

2217

1.72

29.32

1.1

0.45

0.36

u/ml

0.23

174

633

(4024509) Urine culture

1112

5339

1.47

29.30

2.0

1.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

136

310

3.05

29.01

1.5

1.2

16.62

16.51

umol/l

0.09

110

274

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

794

3557

1.57

28.99

1.4

1.5

19.94

13.28

iu/ml

0.40

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

603

2524

1.67

28.97

2.5

2.3

0.95

0.84

nmol/l

2.70

501

2185

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

548

2236

1.72

28.92

1.8

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

190

522

2.54

28.81

1.5

1.3

1353013.54

2938626.22

iu/ml

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

301

1016

2.07

28.42

1.1

1.3

115.45

114.35

pmol/l

0.13

301

1016

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

506

2038

1.74

27.98

1.1

2.20

3.03

1.60

396

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

144

349

2.87

27.68

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

255

816

2.18

27.58

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

446

1744

1.79

27.29

1.2

1.3

52.21

61.97

u/ml

0.25

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

6.67

26.55

1.3

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

954

4534

1.48

26.47

2.4

95.67

94.10

1.27

918

4380

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

241

772

2.18

26.03

2.1

2.3

102.93

98.04

1.13

226

720

(4094501) Cardiovascular stress test using bicycle ergometer

808

3726

1.52

25.93

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

514

2128

1.69

25.77

1.1

2.62

3.15

eliau/ml

0.63

246

1117

(3027923) C peptide [Moles/volume] in Serum or Plasma

201

600

2.33

25.62

1.7

1.49

1.23

nmol/l

2.15

141

471

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

488

1996

1.71

25.58

1.3

—

20.00

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

525

2191

1.68

25.56

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

172

479

2.50

25.44

1.4

1.3

0.30

g/l

0.42

140

391

(40768443) Skin Pathology biopsy report

1188

5927

1.41

25.43

1.2

—

(3007463) Buprenorphine [Presence] in Urine

+∞

25.19

7.0

0.0

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

+∞

25.19

1.3

0.0

189.37

—

nmol/l

—

(3017509) Phencyclidine [Presence] in Urine

116

4.31

25.11

1.4

1.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

900

4287

1.47

24.70

2.9

2.8

3.60

g/l

0.03

858

4125

(43055514) Macroprolactin [Presence] in Serum or Plasma

132

326

2.82

24.60

1.3

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

529

2239

1.65

24.43

1.1

64.11

946.85

iu/ml

0.79

104

458

(3017315) Amylase [Enzymatic activity/volume] in Urine

186

550

2.36

24.24

1.4

1.2

359.09

384.29

u/l

0.09

172

512

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

297

1062

1.95

24.02

1.1

7.62

8.07

iu/ml

0.11

308

(3002256) Pathology report gross observation

3193

18389

1.23

24.01

1.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

149

398

2.61

23.99

2.8

2.4

55.83

48.71

umol/l

2.03

131

356

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

273

948

2.01

23.97

1.3

1.4

12.16

12.19

umol/l

0.02

257

915

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3509

28765

0.82

23.89

3.7

21.75

21.93

0.25

1313

12175

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

160

446

2.50

23.66

1.4

1.2

110.63

110.94

0.05

147

406

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

317

1174

1.88

23.13

1.5

1.3

1.30

1.40

nmol/l

1.05

284

1062

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

164

470

2.43

22.90

1.1

1328.69

411.13

ng/l

0.38

142

(3010015) Selenium [Moles/volume] in Serum or Plasma

4.80

22.89

2.1

1.8

1.36

1.31

umol/l

0.42

(3014271) Vancomycin [Susceptibility]

112

263

2.96

22.84

3.0

2.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

686

3145

1.53

22.65

2.0

1.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

280

1004

1.94

22.50

1.2

—

(3005570) Glucose [Moles/volume] in Urine

292

1066

1.91

22.27

2.1

1.7

—

40.22

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

339

1301

1.82

22.15

1.2

57.03

63.81

u/l

1.40

296

1159

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

109

257

2.95

22.09

1.8

2.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

114

276

2.87

22.07

2.3

3.2

27.54

28.57

umol/l

0.39

225

(3006922) Hepatitis E virus Ab [Presence] in Serum

298

1099

1.89

22.05

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

201

642

2.18

21.96

1.7

1.8

136.58

145.87

1.06

193

611

(3040151) Glucose [Moles/volume] in Capillary blood

290

1062

1.90

21.92

5.6

4.5

7.18

7.09

mmol/l

0.14

240

862

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

156

3.56

21.80

1.4

1.3

0.42

0.26

nmol/l

0.91

112

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

172

516

2.32

21.76

1.8

1.6

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

343

1330

1.80

21.69

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

128

3.85

21.55

1.2

59.87

62.95

ug/l

0.62

128

(3045683) HLA typing for celiac disease panel - Blood or Tissue

248

866

2.00

21.50

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

148

418

2.46

21.35

1.1

94.76

90.26

0.85

200

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

358

1422

1.76

20.90

1.2

55.86

48.07

u/ml

0.19

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

149

428

2.42

20.76

1.2

115.76

107.39

1.49

138

389

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

821

3986

1.44

20.45

2.1

2.0

2.00

2.58

ug/l

0.62

735

3632

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1243

6474

1.35

20.44

11.2

10.9

16.40

16.21

1.04

1206

6239

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

601

2739

1.53

20.43

1.5

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

144

411

2.44

20.35

1.1

1.2

95.20

90.00

0.62

201

(3032057) Clostridioides difficile [Presence] in Stool

134

3.68

20.28

1.8

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

154

3.47

20.26

1.3

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

536

2389

1.57

20.12

1.7

2.0

5.49

5.37

mmol/24h

0.20

491

2194

(3034274) Bile acid [Moles/volume] in Serum --fasting

496

2172

1.60

20.07

2.1

2.3

5.58

6.61

umol/l

0.89

368

1592

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

174

3.28

19.76

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

533

2383

1.56

19.75

1.2

1.3

3.15

3.85

u/ml

1.25

235

1180

(40757494) Bilirubin.total [Moles/volume] in Blood

148

434

2.37

19.75

2.2

17.41

36.90

umol/l

0.75

(3035320) C reactive protein [Mass/volume] in Body fluid

248

899

1.92

19.38

3.2

2.0

22.41

29.17

mg/l

1.99

167

627

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

303

1174

1.80

19.27

1.2

88.85

65.92

u/ml

0.55

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

505

2249

1.57

19.05

1.2

1.3

95.56

152.00

titre

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

311

1219

1.78

19.04

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

231

2.89

18.86

1.2

0.08

0.28

u/ml

1.08

225

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

514

2308

1.56

18.71

1.5

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1437

7746

1.30

18.60

2.8

122.26

163.76

ng/l

4.68

1288

7047

(40759836) Histone Ab [Presence] in Serum by Immunoblot

304

1193

1.78

18.55

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

974

4958

1.38

18.54

1.6

1.5

0.82

5.37

iu/ml

0.59

158

862

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

193

3.06

18.43

1.5

1.6

5.34

6.14

nmol/l

0.95

187

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

231

2.86

18.33

1.1

1.65

2.26

u/ml

0.21

149

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

498

2234

1.56

18.22

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

284

1099

1.80

18.17

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

652

3101

1.47

18.11

1.6

1.7

12754.98

12740.27

e6/l

0.00

468

2256

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

502

2263

1.55

17.98

1.5

1.4

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2702

22158

0.83

17.90

2.7

2.8

0.64

0.74

ug/l

2.82

1664

12120

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

495

2227

1.55

17.89

1.2

1.3

403.64

364.30

titre

0.11

158

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

298

1178

1.76

17.77

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

298

1179

1.76

17.72

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

289

1134

1.78

17.67

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

750

3684

1.42

17.58

2.5

2.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

289

1136

1.77

17.57

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

241

2.77

17.52

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

140

424

2.30

17.45

1.2

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

140

424

2.30

17.45

1.2

1.5

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

664

3194

1.45

17.42

1.3

1.5

35.92

23.90

u/ml

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

649

3109

1.46

17.39

1.6

1.7

—

(3001556) Androgen free Index in Serum or Plasma

129

3.50

17.36

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

132

391

2.35

17.30

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

624

2977

1.47

17.09

1.6

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

443

1967

1.57

16.98

1.6

1.9

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

174

584

2.07

16.91

1.2

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

242

2.73

16.90

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

250

2.70

16.88

1.1

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

663

3208

1.45

16.87

1.4

1.5

—

(3049717) Cytology report of Urine Cyto stain

714

3503

1.43

16.86

2.2

2.7

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

112

3.66

16.79

1.0

0.22

1.40

u/ml

0.69

(4146454) Self-monitoring of blood glucose

276

1090

1.76

16.55

2.7

2.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

869

8081

0.74

16.45

1.1

0.66

0.63

ratio

0.51

100

914

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

278

1104

1.75

16.36

1.3

169.36

247.17

titre

0.83

173

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

277

1099

1.76

16.36

1.3

167.50

260.00

titre

0.34

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

103

279

2.57

16.30

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

310

1271

1.70

16.30

3.7

6.3

99.45

115.56

u/ml

0.15

494

(3008116) Ketones [Moles/volume] in Urine by Test strip

187

2.94

16.03

1.8

1.3

0.12

0.30

mmol/l

1.30

(3012494) Peanut IgE Ab [Units/volume] in Serum

123

366

2.34

16.00

1.1

1.56

3.27

u/ml

0.64

215

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

529

2477

1.49

15.93

1.2

1.3

2.53

3.36

u/ml

1.00

188

999

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

235

898

1.82

15.74

3.0

2.6

0.79

0.63

e9/l

5.63

226

867

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

279

1124

1.73

15.65

1.4

1.3

186.24

188.14

pmol/l

0.02

279

1124

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

343

1462

1.64

15.60

7.8

6.6

11.52

11.33

mg/l

0.32

320

1375

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

169

579

2.03

15.59

1.2

1.4

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1071

5683

1.32

15.55

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

293

1200

1.70

15.50

1.5

2.0

—

(3002079) Sodium [Moles/time] in 24 hour Urine

171

590

2.02

15.48

1.2

149.02

162.32

mmol/24h

1.42

171

590

(3002523) Influenza virus A Ag [Presence] in Specimen

665

3274

1.42

15.44

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

927

4827

1.34

15.31

5.5

4.7

1.82

1.58

4.91

884

4572

(3023419) Bacteria identified in Sputum by Culture

320

1348

1.65

15.25

2.7

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

224

2.70

15.22

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

662

3272

1.41

15.04

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

612

2988

1.43

14.89

1.4

1.5

152.78

148.22

au/ml

0.38

158

864

(3038026) Centromere Ab [Units/volume] in Serum

253

1007

1.75

14.83

1.2

67.63

57.92

u/ml

0.17

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

244

2.59

14.74

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

479

2240

1.49

14.56

1.1

122.74

117.23

3.11

439

2059

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

111

3.44

14.40

1.0

0.19

1.90

u/ml

0.49

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

186

679

1.91

14.39

1.2

22.49

21.48

u/l

0.08

164

623

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

101

3.58

14.38

1.0

1.00

0.28

u/ml

0.38

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

194

719

1.88

14.34

1.6

7.17

6.44

u/l

0.29

147

594

(3020491) Glucose [Moles/volume] in Blood

228

890

1.78

14.30

1.5

1.7

6.72

6.39

mmol/l

0.89

172

639

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

220

2.65

14.26

1.2

483.69

286.86

pmol/l

0.48

168

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

495

2344

1.47

14.16

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

213

2.68

14.14

1.1

—

(21494755) Public health laboratory ask at order entry panel

2529

20452

0.84

14.08

1.3

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

430

1987

1.51

13.87

1.3

1.5

23.88

12.75

u/ml

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

968

8656

0.77

13.87

1.2

1.1

0.89

g/l

0.05

963

8634

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

185

685

1.88

13.74

1.2

85.43

79.82

u/l

0.34

164

627

(4195642) Thrombophilia screening test

472

2231

1.48

13.64

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

126

3.20

13.61

1.0

0.01

0.36

u/ml

1.58

(3000060) B lymphocytes [#/volume] in Blood

124

398

2.17

13.60

2.5

1.9

0.13

0.24

e9/l

1.00

167

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

379

1712

1.54

13.58

1.4

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

237

951

1.74

13.56

4.4

4.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

147

505

2.02

13.54

1.9

2.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

227

901

1.75

13.49

2.7

2.5

561.03

506.24

e6/l

0.93

179

726

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

140

473

2.06

13.48

1.8

142.28

167.62

2.71

134

451

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

183

2.77

13.47

1.0

79.86

81.75

ug/l

0.12

139

(3011412) CD3 cells [#/volume] in Blood

297

1273

1.63

13.29

2.6

2.4

1402.82

1137.81

e6/l

5.31

251

1120

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

181

2.76

13.22

1.8

1.3

54.19

67.19

ng/l

0.30

135

(37208534) Antinuclear antibody arbitrary concentration in serum

130

431

2.10

13.16

1.1

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1424

8008

1.25

13.07

2.8

3.8

53.32

52.62

u/ml

0.01

1379

7787

(3047181) Lactate [Moles/volume] in Blood

646

3263

1.38

12.99

6.1

5.5

1.33

1.25

mmol/l

1.18

577

2880

(37021550) Renin [Units/volume] in Plasma --upright

188

2.70

12.84

1.3

65.96

58.47

mu/l

0.15

140

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

3.47

12.78

1.1

—

(21494815) CD4 cells/Lymphocytes in Specimen

285

1224

1.62

12.68

2.2

2.1

41.07

38.36

2.36

279

1203

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.55

12.64

2.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

792

4151

1.33

12.59

3.1

3.3

1.36

1.43

mg/l

1.85

718

3876

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

144

2.94

12.54

1.5

1.3

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

532

2621

1.42

12.39

1.3

3.00

3.85

ug/l

1.87

488

2346

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4636

35562

0.88

12.37

4.5

1.70

2.35

ug/l

4.71

4184

33106

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

262

1109

1.65

12.36

1.5

2.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

3.44

12.33

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

21.97

12.18

1.0

—

mmol/l

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

288

2.29

11.98

1.1

1.2

89.08

88.29

0.05

101

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

230

951

1.68

11.88

2.8

2.7

223.38

229.19

e6/l

0.19

189

807

(3003694) ABO and Rh group [Type] in Blood

7150

45904

1.11

11.86

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

299

1322

1.58

11.84

1.9

2.4

32.27

32.51

0.41

299

1312

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3.60

11.79

1.1

14.72

13.84

nmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

111

362

2.13

11.77

1.7

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

646

3318

1.36

11.76

1.4

1.5

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

192

762

1.75

11.49

1.2

1.3

96.00

91.19

u/l

0.16

164

658

(3033923) Metanephrine [Moles/time] in 24 hour Urine

188

2.59

11.41

1.1

0.78

7.50

umol/24h

0.49

104

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

147

538

1.90

11.40

1.1

1.0

10.30

11.83

u/ml

0.38

101

363

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

330

1506

1.53

11.38

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

132

468

1.96

11.23

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

187

743

1.75

11.17

1.2

1.3

28.11

26.15

u/l

0.13

157

632

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

646

3352

1.35

11.03

3.2

3.8

29.25

46.36

mg/l

3.03

550

2919

(1175426) CD3 cells/Lymphocytes in Blood

243

1044

1.62

10.88

2.2

2.0

76.24

72.81

4.19

229

1013

(3034860) Kappa light chains.free [Mass/volume] in Serum

646

3362

1.34

10.83

3.2

3.8

40.99

49.00

mg/l

1.46

550

2927

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

3.56

10.82

1.0

0.02

0.11

u/ml

1.11

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

231

982

1.64

10.79

2.3

2.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

293

2.21

10.77

1.1

1.2

80.09

76.89

0.21

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

108

3.09

10.74

2.1

1.9

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

307

2.17

10.73

1.1

1.3

106.35

104.60

0.22

288

(3002619) Bacteria identified in Specimen by Culture

263

2.27

10.69

1.3

1.2

—

(3006245) CD3-CD19+ cells/cells in Blood

144

537

1.86

10.59

2.6

2.1

8.34

9.89

0.98

135

499

(3020874) Milk IgE Ab [Units/volume] in Serum

243

1052

1.61

10.56

1.0

1.1

0.71

1.61

u/ml

1.29

314

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

155

594

1.81

10.47

1.2

63.08

99.71

titre

0.39

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

233

1003

1.62

10.37

2.2

2.0

12.70

15.22

4.39

225

981

(3027231) Wheat IgE Ab [Units/volume] in Serum

298

2.17

10.36

1.1

1.0

0.46

0.83

u/ml

1.17

271

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

323

1502

1.50

10.25

1.7

1.6

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

499

2517

1.38

10.23

2.3

2.6

97.41

91.05

ug/min

0.11

313

1616

(3051611) Lipemic interference index of Serum or Plasma

251

1105

1.58

10.20

3.3

3.2

15.19

13.75

index

0.79

154

617

(3014148) Varicella zoster virus Ab [Titer] in Serum

469

2346

1.39

10.11

1.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

288

2.17

10.08

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

120

2.89

10.07

1.1

—

49.09

titre

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

226

974

1.61

10.03

2.7

2.8

—

(4034850) Laboratory test

704

3752

1.31

10.03

10.4

7.6

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

3.63

9.98

1.0

5.36

22.41

u/ml

2.02

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

573

2969

1.35

9.93

3.1

3.7

1.75

4.74

ratio

1.72

287

1705

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

198

2.42

9.89

1.1

1.0

0.03

0.07

u/ml

0.41

135

(3007930) Methemoglobin/Hemoglobin.total in Blood

812

4420

1.28

9.87

5.9

5.0

0.86

0.89

1.43

778

4185

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

333

2.07

9.79

1.0

1.1

—

(3017569) Oxygen content in Arterial blood

130

482

1.87

9.77

2.2

2.1

16.61

16.15

0.86

130

482

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2965

23091

0.88

9.76

1.8

1.9

3.54

3.51

ratio

0.58

2186

17603

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

220

949

1.61

9.75

1.4

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

220

949

1.61

9.75

1.4

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

220

949

1.61

9.75

1.4

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

154

2.62

9.73

1.1

—

(4268621) Lupus anticoagulant assay

365

1758

1.45

9.73

2.3

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

359

1724

1.45

9.72

1.1

97.79

97.32

0.12

341

1635

(3044242) Glucose [Moles/volume] in Arterial blood

128

476

1.87

9.55

2.1

1.9

7.81

8.17

mmol/l

0.52

128

476

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

207

2.35

9.43

2.8

2.6

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

232

1025

1.57

9.33

1.1

1.0

2.55

2.47

u/ml

0.01

239

(3042631) Mycobacterium sp identified in Specimen

281

1296

1.51

9.32

2.8

2.5

—

(3000330) Specific gravity of Urine by Test strip

1059

5990

1.24

9.29

3.3

3.0

1.02

ratio

1.27

925

5383

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

135

516

1.82

9.26

2.5

2.0

27.54

29.86

1.24

127

492

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

204

877

1.62

9.19

2.5

3.7

101.23

174.49

nmol/l

1.54

198

865

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

155

620

1.74

9.14

1.2

16.44

18.63

u/ml

0.06

(3016031) Almond IgE Ab [Units/volume] in Serum

3.06

9.10

1.0

0.25

0.66

u/ml

0.82

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

108

2.89

9.10

1.1

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

170

701

1.69

9.00

1.2

1.1

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

2.98

1.65

mg/l

0.57

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

3.25

1.93

mg/l

0.42

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

2.17

3.42

mg/l

0.70

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

0.84

0.67

mg/l

0.16

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

3.45

4.05

mg/l

0.22

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

2.31

1.45

mg/l

0.83

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

2.54

1.38

mg/l

0.68

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

2.04

2.12

mg/l

0.04

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.98

8.91

1.5

1.12

1.10

mg/l

0.01

(44806420) Estimation of glomerular filtration rate

345

1674

1.44

8.89

2.6

2.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

102

2.93

8.88

1.5

2.11

1.86

mg/l

0.10

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

166

688

1.68

8.65

1.2

1.6

22.13

23.83

u/ml

0.13

112

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

300

1427

1.46

8.60

1.7

1.6

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

251

1152

1.52

8.56

1.1

16.13

19.62

u/ml

1.12

103

479

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

124

2.69

8.53

1.1

1.83

1.86

iu/ml

0.03

(3008757) Leukocyte morphology finding [Identifier] in Blood

240

1093

1.53

8.49

2.5

3.9

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

187

2.34

8.46

1.2

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

142

2.54

8.32

1.0

0.26

0.24

u/ml

0.03

(3033099) Centromere Ab [Titer] in Serum

351

1.94

8.24

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

235

2.16

8.14

1.2

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

116

2.69

8.05

1.0

1.1

0.03

0.04

u/ml

0.04

116

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

462

2400

1.34

7.97

2.9

3.0

411.42

5578.66

u/ml

1.26

125

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

3.60

7.95

1.3

1.1

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

13.88

7.91

1.2

1.1

1.62

2.41

g/l

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

242

1123

1.50

7.88

1.3

1.5

74631.40

103826.39

e6/l

0.37

173

713

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

138

2.52

7.85

1.0

0.05

0.06

u/ml

0.13

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

123

2.60

7.70

1.0

1.3

53.94

62.25

0.38

(3044927) Protein electrophoresis panel - Urine

195

868

1.56

7.69

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

3.06

7.62

1.0

0.16

1.96

u/ml

1.17

(42529582) MDA5 Ab [Presence] in Serum by Line blot

337

1.92

7.60

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

337

1.92

7.60

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

337

1.92

7.60

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

337

1.92

7.60

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

104

2.74

7.58

1.1

0.85

0.66

iu/ml

0.17

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

184

812

1.58

7.54

1.1

1650.65

1437.07

miu/ml

1.68

184

812

(3028433) Virus identified in Specimen by Culture

358

1.88

7.51

1.2

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

3.35

7.47

1.2

1.5

40.29

29.74

0.49

(3000012) Reticulocyte production index

282

1365

1.44

7.45

2.0

2.2

0.91

0.93

0.17

171

904

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

391

2002

1.36

7.44

1.2

1.3

21.30

28.61

u/l

0.90

338

1766

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

2228

17374

0.88

7.40

1.6

3.50

3.52

mmol/l

0.31

1497

11678

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

442

2309

1.33

7.38

1.1

1.2

1.02

1.15

0.12

142

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

266

1277

1.45

7.35

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

288

1413

1.42

7.09

2.5

3.7

4.85

13.32

nmol/l

0.86

272

1364

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

178

792

1.56

7.07

1.4

1.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

170

749

1.58

7.05

1.6

1.7

—

(3017354) Segmented neutrophils/Leukocytes in Blood

254

1221

1.45

6.99

2.2

3.9

56.39

56.87

0.14

224

1087

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

4.39

6.95

1.0

—

(3037756) Immunofixation for Serum or Plasma

394

2044

1.34

6.92

1.6

1.9

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.71

6.84

1.0

0.04

0.23

u/ml

0.49

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

581

3184

1.27

6.83

6.1

6.7

1791.45

1316.31

iu/ml

0.22

513

(4015189) Microbial culture of sputum

220

2.08

6.82

2.3

1.9

—

(40768800) Prostate Pathology biopsy report

199

2032

0.68

6.80

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

109

432

1.75

6.77

1.4

2.5

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

6.24

6.77

1.1

1.0

0.05

0.22

u/ml

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

108

427

1.76

6.76

1.4

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

108

427

1.76

6.76

1.4

2.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

196

902

1.51

6.72

1.1

1.2

1.05

1.06

ratio

1.57

165

753

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.99

6.71

1.3

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

479

2570

1.30

6.66

3.2

2.6

1.49

1.51

mmol/l

0.15

466

2502

(3004451) EKG impression Narrative

126

523

1.67

6.65

1.3

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

112

2.54

6.63

1.0

1.1

—

(44806071) Cardiolipin IgM antibody measurement

186

2.17

6.61

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

142

609

1.62

6.61

2.6

2.9

24.70

321.32

ug/l

1.71

133

585

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

3.23

6.61

1.1

1.5

12.94

15.11

0.13

(3035947) Staphylolysin Ab [Units/volume] in Serum

133

561

1.65

6.61

1.2

1.1

3.30

4.09

iu/ml

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

267

1.95

6.51

1.5

1.6

0.41

ug/l

0.03

200

(3015076) Soybean IgE Ab [Units/volume] in Serum

206

965

1.48

6.50

1.0

0.51

0.41

u/ml

0.17

212

(40768441) Liver Pathology biopsy report

219

1041

1.46

6.43

1.6

1.4

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

143

620

1.60

6.39

1.0

1.1

102.09

96.16

1.45

115

498

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

299

1508

1.38

6.33

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

620

3464

1.25

6.22

3.7

3.5

0.34

0.35

iu/ml

0.17

339

1834

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

195

913

1.48

6.19

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

604

3367

1.25

6.19

1.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

125

2.39

6.15

1.2

1.1

—

(3013466) aPTT in Blood by Coagulation assay

2.83

6.15

1.0

1.1

35.46

38.93

1.70

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

130

2.35

6.08

2.6

2.7

1.03

1.30

mmol/l

0.32

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

139

607

1.59

6.05

1.4

2.1

—

(44806118) Parainfluenza type 4 nucleic acid detection

314

1611

1.36

6.00

1.7

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

314

1611

1.36

6.00

1.7

1.6

—

(44790048) Parainfluenza type 2 nucleic acid detection

314

1611

1.36

6.00

1.7

1.6

—

(3010503) CD19 cells [#/volume] in Blood

171

785

1.51

5.99

2.6

151.84

345.62

e6/l

1.12

164

769

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

199

2.06

5.97

1.4

1.19

1.18

mmol/l

0.07

199

(44790047) Parainfluenza type 1 nucleic acid detection

314

1613

1.35

5.96

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

138

606

1.58

5.89

1.4

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

138

606

1.58

5.89

1.4

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

138

606

1.58

5.89

1.4

2.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

439

2370

1.29

5.88

1.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

3.65

5.85

1.0

4.68

3.84

u/ml

0.08

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

149

669

1.55

5.78

1.4

2.0

192.54

203.09

u/l

0.70

149

662

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

623

3517

1.23

5.73

1.5

1.4

95.65

135.45

pmol/l

2.05

608

3443

(3033942) Copper [Moles/time] in 24 hour Urine

3.32

5.64

1.1

1.2

0.38

1.02

umol/24h

—

(3005011) Chlamydia sp Ab [Titer] in Serum

153

2.18

5.61

1.6

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

122

2.33

5.61

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

282

1.85

5.60

1.2

14.31

10.48

pmol/l

0.29

112

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

297

1.82

5.60

3.6

2.6

5.09

4.92

kpa

0.82

297

(3010370) Gastrin [Moles/volume] in Serum or Plasma

181

2.07

5.58

1.9

1.8

120.45

43.87

pmol/l

0.44

157

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

3.19

5.57

1.0

1.3

0.67

1.43

0.69

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.50

5.56

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

298

1.82

5.55

3.6

2.6

10.31

10.42

kpa

0.14

298

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

+∞

5.40

1.2

0.0

17.90

—

nmol/l

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

+∞

5.40

1.0

0.0

294.32

—

ug/l

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

218

1.94

5.32

1.0

1.1

7.15

7.74

u/ml

0.10

218

(3024263) Appearance of Synovial fluid

130

579

1.56

5.27

1.8

1.9

—

(3004809) Band form neutrophils/Leukocytes in Blood

365

1954

1.30

5.26

2.5

3.8

1.13

1.57

2.31

330

1792

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

3.96

5.21

1.0

0.15

0.97

u/ml

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

102

430

1.65

5.18

1.2

1.1

2.17

4.21

u/ml

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

118

2.29

5.17

1.1

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

373

3300

0.78

5.14

1.2

1.3

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

384

1.68

5.11

3.2

3.3

1.97

1.79

ratio

0.55

355

(3002331) Protein [Mass/volume] in Peritoneal fluid

236

1.88

5.11

1.3

24.10

28.29

g/l

1.11

186

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

369

1.69

5.08

1.7

8.69

8.95

ug/l

0.27

369

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

137

2.18

5.07

1.0

0.02

0.58

u/ml

0.89

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

174

2.03

5.07

1.7

1.5

412826.76

301322.65

nmol/l

0.13

152

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

257

1.84

5.04

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

155

726

1.48

5.01

2.1

1.8

2.57

2.80

u/ml

0.07

210

(40768793) Breast Pathology biopsy report

607

3472

1.22

4.98

1.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

2.68

4.90

1.1

1.0

—

(3033799) Differential panel - Peritoneal fluid

337

1.71

4.87

1.9

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

174

839

1.44

4.86

3.6

2.8

42.75

38.25

1.99

445

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

134

614

1.52

4.83

1.6

1.5

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

162

775

1.45

4.73

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

128

586

1.52

4.65

1.6

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

2.88

4.56

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

302

1.72

4.56

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

302

1.72

4.56

1.2

1.1

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

2.61

4.54

1.8

1.3

5.14

18.06

pmol/l

0.96

(3000093) Morphology [Interpretation] in Blood Narrative

211

1068

1.37

4.51

1.2

1.1

—

(3036603) Volume of Urine

203

1021

1.38

4.51

1.5

1.7

2278.35

1966.66

1.56

197

1003

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

303

1.72

4.51

1.2

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.95

4.33

1.4

1.7

42.55

51.98

umol/l

0.66

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

142

2.05

4.33

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

307

1.70

4.32

1.1

26.33

30.10

iu/ml

0.27

307

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

166

1.97

4.31

1.1

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

127

594

1.49

4.21

2.6

162.33

143.47

au/ml

0.17

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.27

4.19

1.0

4.38

8.11

u/ml

0.86

(3005082) Progesterone [Moles/volume] in Serum or Plasma

213

1095

1.35

4.17

1.4

30.66

35.70

nmol/l

1.36

190

1033

(3003329) Lymphocytes/Leukocytes in Synovial fluid

216

1113

1.35

4.16

1.4

1.6

35.78

34.28

0.22

132

719

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

150

1.99

4.10

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

155

759

1.42

4.06

9.2

5.8

267.42

1531.69

u/ml

0.80

117

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

138

663

1.45

4.01

1.6

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

166

1.92

4.00

1.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

399

2242

1.24

3.97

3.5

3.8

—

0.86

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

110

2.14

3.94

1.1

—

(3016228) CD19 cells/cells in Blood

112

519

1.50

3.91

1.8

2.0

7.96

8.32

0.15

107

512

(3043410) Blood group antigens tested for on Red Blood Cells

296

1.67

3.87

1.6

1.7

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

4.29

3.85

1.0

3.93

1.60

u/ml

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

103

2.16

3.77

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

121

577

1.46

3.69

1.5

2.81

2.91

u/field

0.05

421

(40761539) Cells [Type] in Urine sediment by Light microscopy

222

1.75

3.67

1.4

1.2

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

129

624

1.44

3.66

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

102

471

1.50

3.65

3.3

3.0

0.61

mmol/l

0.03

102

471

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

228

1.74

3.62

2.5

3.0

26.05

40.12

mg/l

0.79

(3022493) Free Hemoglobin [Mass/volume] in Plasma

116

551

1.46

3.62

4.0

7.5

1866.22

2553.44

mg/l

0.13

405

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

230

1225

1.30

3.59

1.4

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

188

1.81

3.58

1.0

1.1

—

35.55

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

138

681

1.41

3.52

3.4

3.3

8.80

8.72

mg/l

0.04

109

562

(3020393) Adenovirus Ag [Presence] in Stool

102

2.11

3.48

1.1

1.2

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

2.16

3.47

1.0

1.1

8.60

30.80

u/ml

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.23

3.46

1.7

1.2

316.30

315.13

umol/24h

0.01

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

105

494

1.48

3.46

2.2

2.0

86.62

64.38

ug/min

0.19

117

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

445

1.50

3.40

4.3

4.1

—

(3033086) Enterovirus Ab [Titer] in Serum

2.97

3.32

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

154

783

1.37

3.32

1.1

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

186

977

1.32

3.25

3.0

35.94

61.37

mg/l

0.98

129

689

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

499

4069

0.85

3.23

1.4

1.6

57.04

59.98

ug/l

0.84

499

4069

(3023487) Leukocytes [#/volume] in Peritoneal fluid

423

1.49

3.21

2.5

1.7

8028.00

4456.01

e6/l

0.23

271

(3013166) Neutrophils/Leukocytes in Synovial fluid

318

1.57

3.19

1.2

1.5

40.78

53.71

2.03

275

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

275

1.62

3.18

1.2

—

34.81

u/ml

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

2.68

3.17

1.2

1.55

1.39

1.04

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

138

696

1.38

3.15

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

107

2.01

3.11

1.1

1.71

5.17

umol/24h

0.51

107

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

108

523

1.43

3.11

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.62

3.10

1.5

3.8

3.37

2.15

mu/l

0.26

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.03

3.01

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

368

1.51

2.99

2.1

1.7

19150.05

18947.03

e6/l

0.01

177

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

216

1173

1.28

2.98

1.2

80.99

79.84

0.07

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.31

2.95

1.0

1.2

—

(3018133) Calcium [Moles/volume] in Urine

243

1.63

2.94

1.4

1.9

2.84

2.76

mmol/l

0.10

224

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

448

0.57

2.92

1.1

1.2

65.03

69.39

ug/l

0.23

448

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.35

2.92

1.1

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

140

1.83

2.89

1.0

0.82

12.61

u/ml

0.48

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

144

743

1.35

2.88

1.3

1.1

8.57

10.02

mm/h

0.88

144

743

(21494814) CD8 cells/Lymphocytes in Specimen

110

543

1.41

2.88

1.9

31.68

32.12

0.11

110

543

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

401

1.47

2.83

1.7

1.8

1.88

1.72

ratio

0.33

391

(3004446) Plasmodium sp identified in Blood by Light microscopy

182

1.72

2.83

2.6

2.7

—

(3016750) Collection duration of Urine

124

627

1.37

2.83

2.1

2.5

510.66

494.89

min

1.33

511

(3020650) Glucose [Presence] in Urine

105

516

1.41

2.83

1.8

1.4

0.00

0.06

estimate

3.06

105

516

(3006571) Granulocytes/Leukocytes in Synovial fluid

273

1544

1.23

2.70

1.5

1.6

56.45

54.42

0.34

166

1037

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

188

1655

0.79

2.70

1.4

1.6

7.90

7.54

mmol/l

1.50

178

1590

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.96

2.68

1.1

75.43

91.80

titre

0.75

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.20

2.55

1.1

1.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

184

1002

1.28

2.55

2.0

1.6

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1939

12541

1.08

2.50

3.6

4.8

13.58

28.54

ug/l

2.52

1499

9900

(3013336) Amino acids [Identifier] in Serum or Plasma

3.67

2.48

5.6

2.8

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

419

1.42

2.47

1.5

1.8

—

260.18

iu/ml

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

201

1.62

2.45

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

100

502

1.38

2.44

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.05

2.43

1.0

0.59

0.70

u/ml

0.05

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.91

2.42

1.4

3.2

2.38

703.34

pmol/l

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

2.20

2.42

1.5

1.7

0.89

0.67

umol/l

0.56

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.02

2.40

1.0

1.1

8.04

11.43

u/l

0.43

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

158

854

1.28

2.35

1.9

1.7

2.72

1.61

u/field

0.89

480

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

418

1.41

2.34

2.0

2.2

40.28

40.78

g/l

0.34

418

(3039000) Anion gap in Blood by calculation

373

2206

1.18

2.34

8.5

6.8

11.56

11.12

mmol/l

1.65

342

1982

(3018572) Chloride [Moles/volume] in Blood

373

2207

1.17

2.33

8.5

6.8

104.38

105.41

mmol/l

3.87

342

1984

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

167

1.66

2.30

2.2

2.7

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

173

1.64

2.28

8.0

8.3

63.86

72.35

1.08

136

(40762887) Creatinine [Moles/volume] in Blood

2.07

2.23

1.7

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.00

2.15

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

4.62

2.14

1.2

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

5.78

2.12

1.2

1.0

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

272

1.48

2.08

1.8

1.2

11.50

14.73

g/l

1.76

212

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

205

1.56

2.08

4.5

6.1

58.12

40.55

ug/min

0.53

170

(3009677) Dengue virus Ab [Presence] in Serum

1.97

2.08

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.85

2.06

1.1

1.38

0.85

u/ml

0.21

(3044007) Cell count panel - Peritoneal fluid

359

1.41

2.06

2.3

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

513

1.34

2.04

2.3

1.6

710.50

27547.79

u/ml

1.04

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

168

1.61

2.03

2.4

2.5

7.19

7.61

mmol/l

0.22

(3012565) Volume of 24 hour Urine

112

592

1.31

2.02

1.7

2.2

1990.68

2020.61

0.12

103

545

(3036670) Protein [Mass/volume] in Synovial fluid

349

1.41

2.01

1.4

1.3

40.60

41.23

g/l

0.15

196

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

379

2276

1.16

2.01

1.3

1.4

7.06

6.95

mmol/l

0.32

347

2024

(3034426) Prothrombin time (PT)

503

1.34

2.00

1.2

28.47

28.45

0.01

503

(3017958) Strawberry IgE Ab [Units/volume] in Serum

2.21

1.98

1.1

1.0

0.01

0.14

u/ml

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

267

1561

1.19

1.98

1.4

9.42

7.78

mmol/l

5.58

259

1502

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.88

1.94

1.3

1.1

—

(3013762) Body weight Measured

2.26

1.93

1.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.47

1.93

1.0

1.1

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

187

1.56

1.93

2.2

2.7

24.57

24.32

mg/l

0.04

176

(3006567) Chloride [Moles/time] in 24 hour Urine

2.84

1.92

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.07

1.92

1.5

1.4

—

(4211845) Urine protein measurement

114

609

1.30

1.92

3.0

2.6

—

(3017704) Immunofixation for Urine

100

526

1.32

1.89

1.5

1.9

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

160

896

1.24

1.85

1.3

1.4

5.73

5.44

mmol/l

1.35

150

852

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.71

1.83

1.0

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.00

1.78

1.1

1.2

117.20

119.26

ug/l

—

(3050794) Legionella sp Ab [Presence] in Serum

115

1.69

1.77

1.2

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

4.33

1.77

1.0

—

(4035726) Immunohistochemistry procedure

1802

11794

1.06

1.73

1.4

—

(40765089) Chromosome analysis panel - Blood by G-banded

122

669

1.27

1.72

1.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

462

1.32

1.71

2.0

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

244

1.45

1.71

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.38

1.71

6.5

5.3

0.26

0.25

mmol/l

0.08

(3006462) Nitrate [Presence] in Urine

102

550

1.29

1.65

3.2

2.7

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

212

1.47

1.64

2.7

1.9

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

212

1.47

1.64

1.5

1.7

—

(3012989) Citrate [Moles/time] in 24 hour Urine

2.48

1.64

1.2

1.3

1.65

2.08

mmol/24h

—

(3042951) Complement C1q Ab [Units/volume] in Serum

1.93

1.64

1.2

1.3

—

24.41

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

184

1.51

1.63

1.8

1.7

1.65

1.90

mg/l

0.56

154

(3018001) Oat IgE Ab [Units/volume] in Serum

118

1.65

1.63

1.0

0.22

0.98

u/ml

0.43

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1458

10753

0.94

1.63

1.5

1.6

993.66

1025.26

mu/l

0.54

1189

9283

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

2.64

1.63

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.07

1.60

1.6

1.4

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.20

1.60

1.7

1.1

0.17

1.92

—

(3020876) Protein [Mass/time] in 24 hour Urine

238

1409

1.17

1.59

2.3

2.6

1.29

1.32

g/24h

0.06

126

911

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

684

5190

0.91

1.59

1.5

1.7

—

(3035880) pH of Pleural fluid

501

0.72

1.56

1.3

7.36

7.41

0.64

356

(3032352) Blasts [#/volume] in Cerebral spinal fluid

126

1.60

1.52

1.4

2.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.81

1.52

1.1

1.0

0.07

0.08

0.79

(3012403) Metanephrines [Moles/time] in 24 hour Urine

3.47

1.49

1.6

1.0

—

27.15

—

(3052592) Norovirus Ag [Presence] in Stool

160

1.52

1.49

1.0

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

119

667

1.24

1.44

31.7

29.6

115.08

118.88

ug/l

0.24

548

(3038515) Glucose [Moles/volume] in Venous blood

359

2209

1.13

1.43

3.5

2.7

7.22

7.43

mmol/l

0.75

349

2162

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.54

1.41

1.2

1.1

—

(3034891) Synovial lining cells/cells in Synovial fluid

110

615

1.24

1.37

1.3

1.5

6.24

4.35

0.41

147

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.71

1.37

1.3

1.1

11.59

4.44

u/ml

0.27

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

183

0.57

1.37

1.0

1.34

1.20

mom

0.29

183

(3034614) HLA Ag [Interpretation]

2.12

1.35

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.76

1.35

1.1

0.02

2.22

u/ml

1.37

(40761995) Spermatozoa Progressive [#/volume] in Semen

659

0.78

1.34

3.5

3.3

41.22

45.13

0.88

659

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

659

0.78

1.34

6.9

6.7

9.27

8.84

0.25

659

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.82

1.33

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

120

683

1.22

1.29

2.1

8.06

9.57

mg/l

2.48

100

567

(3007542) Rye IgE Ab [Units/volume] in Serum

1.67

1.28

1.0

0.81

20.83

u/ml

0.48

(3024316) Viscosity of Plasma

1.79

1.28

2.4

1.7

1.83

1.43

mpas

—

(40757373) Influenza virus identified in Isolate

213

1.40

1.27

2.2

1.6

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

2.31

1.26

1.1

68.88

68.81

—

(3022670) pH of Venous cord blood

2.31

1.26

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

723

4647

1.08

1.25

3.4

4.1

271.16

2242.35

u/ml

2.46

615

4049

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

543

1.24

1.23

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

543

1.24

1.23

1.4

1.5

—

(3004775) Volume in Urine collected for unspecified duration

144

839

1.19

1.23

2.2

2.5

664.26

676.38

0.11

115

622

(1617658) Protocol used for examination of sentinel lymph nodes

174

1036

1.17

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.60

1.16

1.6

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

196

1560

0.87

1.14

1.4

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

153

904

1.17

1.14

6.0

7.8

12.29

50.19

ug/l

1.50

605

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

148

1.45

1.13

1.6

1.5

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.68

1.13

1.1

1.0

0.19

0.05

u/ml

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

493

1.24

1.13

1.7

128.24

129.58

au/ml

0.01

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.31

1.11

1.3

2.8

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

2.31

1.11

1.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

326

2033

1.11

1.10

2.4

2.5

34.83

26.82

iu/ml

0.54

205

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.64

1.10

1.1

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.48

1.09

1.0

1.1

3061.20

3003.86

titre

—

(3050129) First trimester maternal screen panel - Serum or Plasma

965

7098

0.94

1.09

1.5

—

(4212803) Bone marrow aspirate examination

1.61

1.08

1.2

1.1

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

2.21

1.07

1.1

1.0

47.17

34.90

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

2.21

1.07

1.1

1.2

1.63

1.87

mg/l

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.21

1.07

2.0

1.2

514.57

381.59

mg/24h

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.08

1.07

1.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

209

1.36

1.06

1.3

1.1

138.63

138.47

mmol/l

0.11

175

(3035285) Chloride [Moles/volume] in Venous blood

185

1117

1.15

1.06

2.5

2.1

105.57

105.45

mmol/l

0.14

185

1105

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

139

1.45

1.05

1.2

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

185

1119

1.15

1.04

2.5

2.1

4.01

mmol/l

0.06

185

1107

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

405

2569

1.09

1.01

3.0

4.0

625.16

902.38

u/ml

0.35

360

2334

(3026250) Tacrolimus [Mass/volume] in Blood

136

806

1.17

1.01

42.7

42.1

7.43

7.36

ug/l

0.14

124

739

(3033705) Calcium.ionized [Moles/volume] in Venous blood

182

1103

1.15

1.00

2.5

2.1

1.20

mmol/l

0.67

182

1091

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.89

1.00

1.7

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

162

974

1.15

1.00

2.1

2.2

159.31

864.87

pmol/l

0.88

164

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.57

0.99

1.8

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

110

642

1.19

0.98

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.65

0.95

1.1

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.94

0.95

1.0

1.1

3.14

3.20

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.78

0.94

1.1

1.0

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.19

0.92

1.2

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

126

1.43

0.92

1.3

1.2

5.57

6.89

mmol/l

0.60

(3006598) pH of Arterial cord blood

1.98

0.91

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

202

1244

1.13

0.90

1.9

1.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

107

629

1.18

0.90

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

121

1.43

0.89

1.3

1.4

—

(40758292) HTLV I+II Ab panel - Serum

345

0.76

0.88

1.4

—

(3022475) Manganese [Moles/volume] in Blood

1.51

0.88

1.0

1.3

0.15

umol/l

0.03

(46235168) Fasting glucose [Moles/volume] in Blood

250

0.72

0.88

3.5

1.2

7.90

6.96

mmol/l

0.61

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.85

0.86

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

241

0.72

0.86

6.5

7.0

10.54

10.73

0.15

241

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.58

0.85

4.8

2.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

138

833

1.15

0.85

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

280

1.26

0.84

3.8

2.7

885.37

383.89

ug/l

0.23

280

(3003434) Protein [Mass/volume] in Pleural fluid

166

1300

0.88

0.83

1.5

1.4

33.80

34.36

g/l

0.22

156

1193

(3051387) C reactive protein [Mass/volume] in Capillary blood

426

2740

1.08

0.82

3.6

2.8

25.88

27.19

mg/l

0.25

270

1903

(42528597) U1 small nuclear ribonucleoprotein C Ab [Presence] in Serum by Line blot

1.73

0.81

1.0

—

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.73

0.81

1.0

—

(4133840) Spirometry

532

0.82

0.81

1.2

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

1.54

0.81

9.7

8.1

324.91

297.02

e6/l

0.04

(40768806) Pleura Pathology biopsy report

124

987

0.87

0.80

1.7

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

412

2652

1.08

0.78

4.6

3.4

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.61

0.78

13.6

9.6

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

108

1.41

0.75

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

120

1.39

0.75

1.2

—

(40768446) Kidney Pathology biopsy report

111

668

1.15

0.74

1.6

1.7

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.04

0.73

1.2

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

109

1.40

0.72

1.0

1.1

25.42

22.69

u/l

0.18

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

101

0.62

0.71

1.2

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

275

1.24

0.70

1.7

2.4

—

(3019174) dRVVT (LA screen)

116

1.38

0.69

1.3

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.46

0.68

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.53

0.68

1.0

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

355

1.19

0.63

1.9

2.7

95.69

99.13

ng/l

0.05

194

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.68

0.63

1.0

1.1

25.78

75.40

umol/24h

—

(3032868) Hemoglobin electrophoresis panel in Blood

161

1.29

0.63

1.6

1.5

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

192

1.26

0.62

1.0

—

(3016135) IgD [Mass/volume] in Serum

1.63

0.62

1.0

2.4

35.36

91.59

mg/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

286

1.21

0.62

1.1

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.62

0.0

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

187

0.74

0.62

1.1

1.3

0.36

1.81

mmol/l

—

127

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.40

0.62

1.1

—

(3042733) HLA Ab [Presence] in Serum

595

1.14

0.61

4.4

5.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.54

0.59

1.0

1.1

247.00

268.19

nmol/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

201

1.24

0.57

1.1

1.3

6.14

5.78

mmol/l

1.30

201

(3029612) Listeria sp Ab [Titer] in Serum

1.66

0.56

1.5

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

241

1547

1.08

0.56

3.4

3.0

0.79

0.82

nmol/l

0.50

179

1253

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

114

884

0.89

0.55

1.3

752.78

424.29

u/l

0.72

107

846

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

171

1.26

0.55

2.2

2.9

39.07

82.21

pmol/l

2.00

149

(3018738) Hemoglobin F/Hemoglobin.total in Blood

1.39

0.53

3.6

2.7

18.02

6.30

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.39

0.50

1.7

1.5

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

1.43

0.48

1.2

1.0

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

328

1.16

0.47

1.9

2.0

28.94

29.97

u/l

0.03

305

(3029396) Erythrocyte agglutination [Presence] in Blood

633

0.89

0.47

2.5

3.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

314

0.84

0.46

6.4

7.8

5.27

5.54

kpa

0.36

314

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.31

0.45

3.2

5.9

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

227

1.19

0.45

1.4

1.2

83.86

71.96

mg/l

0.05

157

(3026480) Teichoate Ab [Titer] in Serum

1.32

0.45

1.2

1.0

—

2.67

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.35

0.44

2.5

5.7

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

331

1.15

0.43

1.3

54.03

40.37

1.77

230

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

359

2363

1.05

0.43

3.9

3.8

24.71

41.28

u/ml

2.93

341

2280

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.42

0.0

1.2

—

(3010937) Rubella virus Ab [Presence] in Serum

116

1.26

0.39

1.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

116

737

1.09

0.39

1.2

1.3

1088.00

1099.43

titre

0.03

175

(3043238) Trisomy 21 risk [Likelihood] in Fetus

704

4720

1.04

0.39

1.5

1.6

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

208

0.83

0.35

1.0

1.2

1.65

1.78

mmol/l

0.17

131

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

201

1.17

0.35

1.4

1.5

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.31

0.33

1.0

1.1

—

(3051101) Glucose [Moles/volume] in Cord blood

175

0.83

0.31

7.0

5.4

9.94

8.12

mmol/l

0.91

175

(3046861) Legionella sp Ag [Presence] in Urine

1.28

0.31

1.2

1.0

—

(21494434) Karyotype in Bone marrow

141

1043

0.94

0.30

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

290

1927

1.04

0.29

1.8

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.26

0.28

1.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.28

0.27

6.1

11.3

109.83

108.08

g/l

0.12

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.24

0.27

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.69

0.26

1.0

1.1

—

(3024932) HLA-DR beta [Type]

546

1.08

0.26

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.25

0.25

3.1

2.9

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

111

0.81

0.25

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

207

0.87

0.24

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.72

0.24

1.0

1.5

—

510.00

—

(3023199) Leukocytes [#/volume] in Pleural fluid

158

1153

0.95

0.24

1.5

1.4

4234.04

3072.50

e6/l

0.44

114

792

(3045788) Cell count panel - Pleural fluid

130

953

0.95

0.24

1.6

1.4

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.33

0.23

1.2

1.1

—

(3024471) HLA-A [Type]

556

1.07

0.23

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

813

5526

1.02

0.22

1.4

1.5

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.22

0.0

1.1

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.22

0.0

1.4

—

19.77

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.22

0.0

1.1

—

(4281824) Cell count and differential, peritoneal fluid

227

1636

0.96

0.22

1.1

—

(43055189) Lymphocytes [#/area] in Urine sediment by Microscopy high power field

0.00

0.21

0.0

1.0

—

(3045142) Bone marrow Pathology biopsy report

198

1429

0.96

0.21

1.3

1.4

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.18

0.19

1.1

—

(3005033) Fetal Nuchal fold Thickness US

671

4561

1.02

0.19

1.5

1.25

1.24

0.05

477

3399

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

293

1.09

0.19

2.2

1.8

1.57

3.89

ug/l

0.80

183

(3036782) Glucose [Moles/volume] in Pleural fluid

147

978

1.04

0.17

1.3

6.43

6.11

mmol/l

0.68

137

917

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

127

0.87

0.15

1.1

—

(3001729) Color of Synovial fluid

1.16

0.15

1.3

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.09

0.15

1.8

1.9

0.72

0.69

ug/l

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

821

5613

1.01

0.15

1.4

1.5

1.24

1.18

ratio

0.81

471

3525

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

821

5613

1.01

0.15

1.4

1.5

0.94

ratio

0.01

470

3487

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

144

1034

0.97

0.14

1.4

1.2

—

(40768795) Lymph node Pathology biopsy report

203

1447

0.97

0.13

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

150

1008

1.03

0.12

1.7

1.8

3.42

3.64

mg/l

0.24

142

979

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

818

5603

1.01

0.12

1.4

1.5

1.15

1.19

ratio

0.57

467

3479

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

186

1.08

0.11

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

119

1.11

0.11

1.8

1.9

0.79

0.65

u/field

0.24

119

(3026470) Cobalt [Mass/volume] in Blood

606

0.96

0.11

2.3

2.25

3.88

ug/l

3.18

562

(3022689) Creatine [Moles/volume] in Urine

519

1.04

0.11

1.5

1.4

7.91

8.27

mmol/l

0.29

519

(3047352) Trisomy 18 risk [Likelihood] in Fetus

678

4650

1.01

0.10

1.5

1.6

—

(3005532) Lymphocytes/Leukocytes in Pleural fluid

303

1.05

0.09

1.5

1.4

56.00

61.93

0.47

252

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

511

0.96

0.09

2.3

3.6

1.21

0.00

511

(3028308) Erythrocytes [#/volume] in Pleural fluid

142

1009

0.98

0.09

1.6

1.4

40979.59

38325.31

e6/l

0.08

537

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.77

0.08

1.2

42.58

32.13

mg/24h

—

(4038314) Semen analysis, post vasectomy

196

1.06

0.08

1.2

—

(40765096) Chromosome analysis panel by Banding

381

1.04

0.07

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

494

0.97

0.07

2.0

2.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.06

0.07

1.0

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.04

0.07

1.3

1.2

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.85

0.07

1.6

1.3

—

(3009871) Measles virus Ab [Titer] in Serum

688

0.98

0.06

1.7

1.6

2785.88

3477.93

titre

0.47

122

(40758358) Immune stain study

1.12

0.06

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

863

5948

1.01

0.06

1.5

1.6

59.75

63.15

ug/l

1.33

696

5032

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

406

0.97

0.04

1.3

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

446

3114

0.99

0.04

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

158

1082

1.01

0.04

2.1

2.3

—

(3026726) Creatinine [Moles/volume] in Specimen

104

1.07

0.04

1.9

2.3

771.25

261.77

umol/l

0.84

(3025577) Chromium [Mass/volume] in Blood

593

0.98

0.03

2.3

1.97

2.65

ug/l

1.45

496

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.08

0.03

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.92

0.02

5.3

5.0

—

(40762814) Titanium [Mass/volume] in Blood

178

0.97

0.01

3.0

2.6

3.66

4.55

ug/l

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.03

0.00

3.5

3.7

—

(40763590) HLA-DQ beta [Type]

1.00

0.00

1.0

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

140

0.99

0.00

1.5

1.3

12.27

15.71

0.30

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

155

0.98

0.00

1.2

1.5

—

(3014891) Appearance of Pleural fluid

101

1.03

0.00

1.5

1.7

—

(3003577) Lead [Moles/volume] in Blood

149

1.02

0.00

1.3

1.6

0.29

0.40

umol/l

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

261

1.01

0.00

1.6

1.4

4.10

2.20

0.66

223

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

226

1.01

0.00

1.2

1.3

80.13

245.10

ug/l

1.02

121

(3013862) HLA-DP [Type]

0.97

0.00

1.0

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

1.03

0.00

3.1

1.8

67.00

64.19

—

(46236302) HLA-C [Type] by High resolution typing

0.99

0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

0.99

0.00

1.0

—

(40760410) HLA-B [Type] by High resolution

0.99

0.00

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.94

-0.00

1.6

1.9

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

-0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.98

-0.00

1.0

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.97

-0.00

1.2

1.1

209.33

260.67

u/ml

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.90

-0.00

1.0

1.1

—

(3025311) HLA-B [Type]

0.00

-0.00

0.0

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

10.5

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.01

-0.00

1.5

1.9

—

36842.86

—

(36304079) Mucus [Presence] in Urine sediment

0.00

-0.00

0.0

1.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: F5_DEPRESSION_RECURRENT – Recurrent or chronic depression

GWS hits: 42

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Recurrent or chronic depression

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Recurrent or chronic depression (F5_DEPRESSION_RECURRENT)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints